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Real-Time Imaging of Hippocampal Network Dynamics Reveals
Trisynaptic Induction of CA1 LTP and "Circuit-Level" Effects of
Chronic Stress and Antidepressants
Abstract
Today’s pervasive presence of stress renders stress-related psychiatric disorders (SRPDs),
a relevant global health problem. Memory impairment is a major symptom likely medi-
ated by the hippocampus (HIP), a limbic brain region highly vulnerable to stress. Recent
evidence suggests that information processing problems within specific neuronal net-
works might underlie SRPDs. However, the precise functional neurocircuitry that medi-
ates hippocampal CA1 long-term potentiation (LTP), a putative correlate of mammalian
learning and memory, remains unknown at present. Furthermore, valuable assays for
studying stress and drug effects on polysynaptic activity flow through the classical in-
put/output circuit of the HIP are missing.
To engage a circuit-centered approach, voltage-sensitive dye imaging was applied in
mouse brain slices. Single pulse entorhinal cortex (EC) to dentate gyrus (DG) input,
evoked by perforant path stimulation, entailed strong neuronal activity in the DG, but
no distinct neuronal activity in the CA3 and CA1 subfield of the HIP. In contrast, a theta-
frequency (5 Hz) stimulus train induced waves of neuronal activity percolating through
the entire hippocampal trisynaptic circuit (HTC-waves). Spatially restricted blocking
of glutamate release at CA3 mossy fiber synapses caused a complete disappearance of
HTC-waves, suggesting frequency facilitation at DG to CA3 synapses the pivotal gating
mechanism. In turn, non-theta frequency stimulations (0.2/1/20 Hz) proved much less
effective at generating HTC-waves.
CA1 long-term potentiation (CA1 LTP) is the best understood form of synaptic plasticity
in the brain, but predominantly at the monosynaptic level. Here, HTC-waves comprise
high-frequency firing of CA3 pyramidal neurons (>100 Hz), inducing NMDA receptor-
dependent CA1 LTP within a few seconds. Detailed examination revealed the existence
of an induction threshold for LTP. Consequently, baseline recordings with a reduced
number of HTC-waves were carried out to test the effects of memory enhancing drugs
and HPA axis hormones on hippocampal network dynamics. Bath application of caffeine
(5 µM), corticosterone (100 nM) and corticotropin-releasing hormone (5 & 50 nM) rapidly
boosted HTC-waves.
Cognitive processes taking place within the HIP are challenged by stress exposure, but
whether and how chronic stress shapes "net" neuronal activity flow through the HIP
remains elusive. The HTC-wave assay, refined for group comparisons, revealed that
chronic stress markedly lowers the strength of evoked neuronal activity propagation
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through the hippocampal trisynaptic circuit. In contrast, antidepressants (ADs) of several
classes, the mood stabilizer lithium, the anesthetic ketamine, and the neurotrophin brain-
derived neurotrophic factor amplified HTC-waves. An opposite effect was obtained with
the antipsychotic haloperidol and the anxiolytic diazepam. The tested ADs exert this ef-
fect at low micromolar concentrations, but not at 100 nM, and nearly always, also not
at 500 nM. Furthermore, the AD fluoxetine was found to facilitate LTP of HTC-waves.
Finally, pharmacological blockade of the tyrosine-related kinase B receptor abolished flu-
oxetine effects on HTC-waves.
These results highlight a circuit-centered approach suggesting evoked synchronous theta-
rhythmical firing of EC principal cells as a valuable tool to investigate several aspects of
neuronal activity flow through the HIP. The physiological relevance is emphasized by
the finding that the resulting HTC-waves, which likely occur during EC theta oscilla-
tions, evoke NMDA receptor-dependent CA1 LTP within a few seconds. Furthermore,
HTC-waves allow to integrate molecular, cellular and structural adaptations in the HIP,
pointing to a monoaminergic neurotransmission-independent, "circuit-level" mechanism
of ADs, to balance the detrimental effects of chronic stress on HIP-dependent cognitive
abilities.
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Chapter 1
Introduction
Modern society is faced with ubiquitous and universally pervasive stress (Chrousos,
2009). Stressors may be broadly defined as any physiological or emotional stimuli that
overwhelm homeostatic systems of an organism (Radley, 2012). Multiple strands of evi-
dence have established a robust and causal association between higher levels of signifi-
cant stressors and stress-related psychiatric disorders (SRPDs) (Hammen, 2005; Sapolsky
et al., 1986; McEwen and Gianaros, 2011).
Most common among SRPDs is major depression (MD). Meta-analysis of epidemiologi-
cal surveys found that the lifetime prevalence of MD is in the range of 10-15%, affecting
over 340 million people worldwide (Lépine and Briley, 2011; Slattery et al., 2004). The
World Health Organization estimates that MD will become the leading cause of burden
of disease by the year 2030, even before ischemic heart disease (WHO, 2004). However,
modern pharmacological treatment regimes with antidepressant (AD) drugs largely de-
pend on substances discovered more than half a century ago, and response rates are
considerably low, leaving about 20-30% of patients without effect. Even if treated by
mental-health specialists and remission is achieved, MD is rarely accompanied by a total
disappearance of all symptoms (Berton and Nestler, 2006; Duman and Aghajanian, 2012;
Kallarackal et al., 2013; Lépine and Briley, 2011; Ressler and Mayberg, 2007; Trivedi et al.,
2006).
Equally common are anxiety disorders (AXDs) including extremely debilitating diseases
like post-traumatic stress disorder, panic disorder, and phobias. They are frequently diag-
nosed with a combined lifetime risk of over 28%, raising a similar socioeconomic burden
compared to that of MD paralleled by considerably low response rates to pharmacologi-
cal intervention (Ressler and Mayberg, 2007; Shin and Liberzon, 2010).
In this thesis, SRPDs are pooled together for the following reasons: (i) High comorbid-
ity between SRPDs (e.g., up to 90% between AXDs and depressive episodes); (ii) SRPDs
share a variety of symptoms impeding the diagnostic classification; (iii) a highly over-
lapping fashion of neurocircuits considered to be involved; (iv) similar pharmacological
(ADs) and psychological (cognitive behavioral therapy) treatment strategies (Holsboer et
al., 2012; Ressler and Mayberg, 2007).
A vital factor that a coherent cause or cure for SRPDs is non-existing might be the hetero-
geneous character of these brain disorders, likely resulting from a complex interplay of
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environmental and genetic factors (Holsboer, 2008). Due to the lack of specific tests and
markers, their diagnosis is still clinical based with the aid of core signs and symptoms
(e.g., MD; depressed mood, anhedonia, changed appetite and weight, sleep disturbances,
feelings of helplessness and thoughts about death and suicide; Duric and Duman, 2013;
Richelson, 2001).
Although it is increasingly thought that much of the phenomenology of SRPDs is at-
tributable to problems of information processing within distinct neuronal networks (Cas-
trén, 2005), there is an incomplete understanding of circuit-level mechanisms associated
with the pathophysiology and pharmacotherapy of these disorders (Karayiorgou et al.,
2012).
The hippocampus (HIP), a temporal lobe structure, is one brain region intimately linked
to the pathophysiology of SRPDs. Multiple strands of evidence suggest a critical role for
the HIP in the acquisition and retention of new information, a process that is often asso-
ciated with theta (3-8 Hz) activity in the entorhinal-parahippocampal network (Burgess
et al., 2002; Buzsàki, 2002; Gruart et al., 2006; Mitchell et al., 1982; Morris et al., 1986;
Rutishauser et al., 2010; Stepan et al., 2012; Tsien et al., 1996; Whitlock et al., 2006; Win-
son, 1978; Zola-Morgan et al., 1986). Although a decline in cognitive functions is strongly
associated with SRPDs, it is not known how polymodal sensory information is gated
through the hippocampal network for subsequent storage (MacQueen and Frodl, 2011;
McEwen and Gianaros, 2011). Extensive research to find cellular surrogates for learning
and memory was done over the last 50 years, but, due to the lack of suitable methods,
this happened predominantly at the monosynaptic level. Consequently, the neuronal
network dynamics that lead to polysynaptic induction of CA1 long-term potentiation
(LTP) at the hippocampal CA3 to CA1 synapse, a widespread experimental model for
studying the cellular underpinnings of learning and memory remain elusive (Bliss and
Collingridge, 1993).
Beyond its role in synaptic plasticity, the HIP is both, a key contributor to the neuroen-
docrine stress response and severely damaged by prolonged stress exposure. This dual
function potentially promotes a self-amplifying dysregulation of stress response, likely
mediating alterations in behavior and emotions that are characteristic for SRPDs (Kim
and Diamond, 2002; Sapolsky et al., 1986). Numerous studies conducted on the micro-
(e.g., single-cell recordings, (epi-)genetics) and macro-scale (fMRI, clinical studies) yield
valuable insight into possible mechanism of disregulated stress response. However, the
underlying disordered electrical signaling patterns in specific brain circuits are poorly
understood (McEwen and Gianaros, 2011).
ADs have been shown to counterbalance detrimental effects of stress and especially the
HIP is suggested to be a possible side of their action (Krishnan and Nestler, 2008). How-
ever, ADs represent a heterogeneous group of drugs showing a high variability of ef-
fectiveness according to specific subtypes of SRPDs, likely mediated by the induction
of multifarious molecular, cellular and structural changes upon treatment (Berton and
Nestler, 2006; Duric and Duman, 2013). Consequently, it seems difficult to integrate all
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these mechanism for prediction of the outcome on the neuronal circuit level or even be-
havior. Therefore, more circuit-centered electrophysiological approaches might be suited
to elucidate convergent processes of AD drug action at the level of input/output rela-
tionships in the HIP (Karayiorgou et al., 2012).
1.1 The hippocampal formation
The dentate gyrus (DG), the ammon’s horn (cornu ammonis (CA), with its subregions
CA3, CA2 and CA1), the subiculum (SUB), the presubiculum (PRE), the parasubiculum
(PARA), and the entorhinal cortex (EC), are summarized under the term hippocampal
formation (HF) (Amaral and Witter, 1989). Beyond this shared anatomical identity, they
comprise six cytoarchitectonically distinct brain regions, considered as integral compo-
nents of the medial temporal lobe system (Figure 1.1; Amaral and Witter, 1989).
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Fig. 1.1. Anatomy of the hippocampal formation. Expansion of the c-shaped HIP from the septal nuclei
(S) to the temporal lobe (T) in the rodent brain (adapted from Amaral and Witter, 1989). The outtake de-
picts a cross-section through the transverse axis (TRANS) of the HIP which is oriented perpendicular to the
septotemporal axis.
The rodent HIP (here: DG and CA-subregions) appears as an elongated, banana-shaped
structure situated in the caudal part of each brain hemisphere with a long or septotem-
poral axis running from the septal nuclei rostrally to the temporal cortex ventrocaudally
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(Figure 1.1; Amaral, 1993; Amaral and Witter, 1989; Andersen et al., 2006). Connectiv-
ity patterns, gene expression profiles and behavioral studies support a functional seg-
mentation of the HIP along its rostral/caudal axis into three subdivisions: dorsal/rostral
(septal pole), intermediate, and ventral/caudal (temporal pole). Although clear borders
are difficult to draw, the dorsal part is often associated with cognitive functions, whereas
the ventral part is related to stress, emotion and affect (Fanselow and Dong, 2010). CA-
subregions and the DG share a characteristic three-layered appearance with largely uni-
directional connectivity. Contrarily, the SUB, PRE, PARA, and EC are characterized by
reciprocal connectivity and more than three layers, although discrimination between lay-
ers is sometimes difficult (Watson et al., 2011; van Strien et al., 2009).
A highly topographical organization along its septotemporal- and transverse axis is char-
acteristic for the HF and connectivity between its different parts is mediated via specific
fiber bundles. Examples include the angular bundle, which is made up by axons con-
necting the EC with all other fields of the HF or the fimbria-fornix pathway, mediating
connectivity between the HF and the basal forebrain, hypothalamic nuclei, and the brain
stem (Figures 1.1, 4.16; Watson et al., 2011; Andersen et al., 2006).
1.1.1 Cytoarchitecture of the hippocampal formation
The EC closely resembles the standard six layer scheme, which is characteristic for the
neocortex with five cell body layers and a superficial molecular layer. However, principle
cell distribution is different from the neocortex. The most prominent excitatory cells are
stellate cells and pyramidal cells, situated predominantly in layers II and III. Layers I-III
usually refer to external and layers IV-V to internal principal layers. Due to differences
in cytoarchitecture, connectivity, and function, the EC can be subdivided into a medial
entorhinal cortex (MEC) and a lateral entorhinal cortex (LEC) (Figure 1.1; Andersen et al.,
2006; Patton and McNaughton, 1995; Watson et al., 2011).
The DG is not divided into subregions but differs remarkably in its shape along the longi-
tudinal axis with a more "U"-shaped anatomy in ventral, and a more "V"-shaped anatomy
in dorsal parts. It has been reported that functional differences may be present along the
transverse axis of the granule cell layer (Witter, 2007). Therefore, it is useful to refer
to a particular transverse portion of the DG. The part situated between area CA1 and
CA3, is referred to as suprapyramidal or inner blade and the part inferior to area CA3
as the infrapyramidal or outer blade. The region linking the two blades (at the kink of
the "V" or "U") is called the crest (Figure 1.1; Amaral et al., 2007; Claiborne et al., 1986;
Patton and McNaughton, 1995).
The DG is composed of three layers. The deep layer (adjacent to CA3) is called hilus or
polymorphic layer (PL) and contains mixed fibers and interneurons. The principal cell
layer or granule cell layer (GCL) predominantly contains densely packed granule cells.
The molecular layer (ML) represents the most superficial layer and is cell free apart from
a few interneurons. The granule cell layer and molecular layer together are sometimes
referred to as the fascia dentata. The major components of the ML are the axons of the
perforant pathway (PP) (part of the angular bundle), which originates in the EC and
1.1. THE HIPPOCAMPAL FORMATION 5
the dendrites of the dentate granule cells. In addition, a variety of subcortical inputs
establish synapses on dendrites in this layer (Figure 1.1; Amaral et al., 2007; Patton and
McNaughton, 1995; Claiborne et al., 1986; Watson et al., 2011; Witter, 2007).
Comparatively, the first two layers of the CA region are composed of a deep layer called
stratum oriens (SO), containing basal dendrites followed by pyramidal cell layer (PCL),
the principle cell layer. The basic organization is completed by the ML. This most su-
perficial layer is divided into a number of sublayers in the CA subregions. The stratum
lucidum (SL) only exists in areas CA2 and CA3 and contains proximal apical dendrites
of pyramidal cells. The stratum radiatum (SR) is situated in the middle and contains
the distal apical dendrites of the pyramidal neurons followed by stratum lacunosum-
moleculare (SLM) adjacent to the hippocampal fissure, comprising the pyramidal neu-
rons apical tufts of the apical dendrites (Figure 1.1; van Strien et al., 2009; Andersen et al.,
2006).
1.1.2 Connection matrix of the hippocampal formation
The EC constitutes the major gateway between the HF and the rest of the brain. Its neu-
rons represent the main entry point for polymodal (sensory) information routed to the
DG and HIP, and it relays processed sensory information from the HF back to a variety
of brain regions. Thus, the EC is the beginning and the end of a highly topologically ar-
ranged loop of information flow through the HF. The EC relays cortical and subcortical
information via three parallel excitatory inputs, summarized as the so-called PP, to DG
granule cells, CA3/CA1 pyramidal neurons, and interneurons in both fields. By far, the
most prominent input arises from EC layer II stellate cells to the entire transverse extent of
the DG converging onto the apical dendrites of dentate principal cells and interneurons.
Specifically, the LEC (via lateral PP), projects to the outer third of the molecular layer of
the DG, and the MEC (via medial PP) projects to the middle third. In addition, there is
a slight projection from EC layer II cells onto distal apical dendrites of CA3 pyramidal
cells in SLM, with a comparable convergence of MEC/LEC inputs. The origin of the main
projection from the EC to SLM of area CA1 lies in layer III, also known as temporoamonic
pathway forming synapses on distal apical dendrites of CA1 pyramidal cells (Figures 1.1,
4.1; Andersen et al., 2006; Boeijinga and Van Groen, 1984; Patton and McNaughton, 1995;
van Groen et al., 2003; van Strien et al., 2009). Although these connections are well es-
tablished, recent studies point out strain differences. It was reported that layer II stellate
cells in C57BL/6J mice project exclusively to the DG and that projections to CA3 originate
from EC layer III cells (van Groen et al., 2003).
1.1.2.1 The entorhinal cortex layer II stellate cell
Stellate cells constitute the dominant cell type in layer II of the EC. They received this
name from their star-shaped arborization and spanning, with numerous dendrites ra-
diating out from the soma. The most striking physiological features of layer II stellate
cells are rhythmical changes in network activity at 3-10 Hz, as observed in local field
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potential recordings. These theta oscillations occur in response to subthreshold depolar-
izations, and recent work suggests them being the key contributor to theta rhythm gen-
eration in the EC-hippocampal network (Alonso and Llinás, 1989; Andersen et al., 2006;
Mizuseki et al., 2009; Mitchell et al., 1982; Quilichini et al., 2010). The role of EC theta
oscillations in animal cognition is well established. Their elimination results in deficits
of spatial memories, and layer II stellate cells are selectively impaired in their function
in animal models of Alzheimer’s disease (Mitchell et al., 1982; Stranahan and Mattson,
2010). In comparison to excitatory cells in other layers, layer II stellate cells show strong
modulation of their spiking to specific phases of theta oscillations and include the high-
est fraction of significantly theta-modulated neurons (Quilichini et al., 2010). A subset of
layer II stellate cells in the dorsocaudal medial EC represents a specific example for mod-
ulation of spike patterns. These cells form a topographically organized neuronal map of
the spatial environment. These so-called grid cells fire whenever the animal’s position co-
incidences with any vertex of a regular grid of equilateral triangles spanning the surface
of an environment and were found in all mammals including humans (Fyhn et al., 2008;
Hafting et al., 2005; Jacobs et al., 2013). Grid cells exhibit phase modulation of their
spikes to specific spacial cues (e.g., when the rat runs through the receptive field of a
subset of neurons), suggesting an important computation mechanism in the EC. Over-
all, phase modulation of stellate cell spiking by theta oscillations provides a possible
mechanism by which the EC entails sequences of theta-rhythmical spiking in EC layer II
cells, thereby effectively routing sensory information to the HIP (Alonso and Llinás, 1989;
Burgalossi et al., 2011; Mizuseki et al., 2009).
1.1.3 The trisynaptic pathway of the hippocampus
The DG receives its major input from the EC via the PP. Granule cells of the DG, the
only cells that give rise to axons (mossy fiber (MF)) leaving this structure (syn.: principle
cell), synapse on pyramidal neurons in area CA3. These neurons in turn, pass electrical
signals on pyramidal cells in area CA1 via their so-called Schaffer collateral (SC)s. This
set of synapses is referred to as the classical trisynaptic circuit of the HIP (Figures 1.1, 4.1;
Amaral and Witter, 1989; Amaral, 1993; van Strien et al., 2009).
1.1.3.1 The mossy fiber to CA3 synapse
The synaptic contact formed between DG granule cells and CA3 pyramidal cells is rather
unique in having morphological, pharmacological, and physiological features, not usu-
ally observed in cortical synapses (Andersen et al., 2006; Henze et al., 2000). It is the
second synapse of the classical trisynaptic pathway and conveys input on proximal den-
drites of CA3 pyramidal cells (Figure 1.1). Each granule cell of the rodent DG gives rise
to a single unmyelinated axon, known as MF. Immediately after leaving the granule cell
layer of the DG, the main MF gives rise to numerous small filopidal extensions which
synapse on dendrites of polymorphic neurons in the hilus. Afterwards, the main MF
leaves the hilus, establishing synaptic contacts (large MF boutons) in SL on the dendritic
tree of various CA3 principle cells with a limited degree of septotemporal divergence
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(Henze et al., 2000; Amaral and Witter, 1989). Synapses on pyramidal cells show some
distinct features. The total number of mossy terminals along the granule cell axon is rela-
tively small, with very limited convergence (≈ 50 granule cells per pyramidal cell) and di-
vergence (≈ 10-18 pyramidal cells per granule cell). This sparse connection pattern is not
seen elsewhere in the brain (Andersen et al., 2006; Henze et al., 2000; Henze et al., 2002;
Watson et al., 2011). DG granule cells provide their main input onto gamma aminobutyric
acid (GABA)ergic interneurons in SL (via small filopidal extensions), perfectly positioned
to disynaptically inhibit CA3 pyramidal cells following MF activation, which adds onto
the sparse coding between granule cells and CA3 pyramidal cells. This connection pat-
tern is associated with a net inhibition of CA3 pyramidal cells after MF activation (Henze
et al., 2000; Mori et al., 2004). However, an important aspect in this circuitry is the remark-
able frequency facilitation specifically at MF to CA3 synapse (up to 1000 %; Nicoll and
Schmitz, 2005; Toth et al., 2000), in response to (theta)-rhythmical synaptic input (Mori et
al., 2004; Toth et al., 2000), accompanied by a switch from net inhibition to net excitation
in the CA3 network.
1.1.3.2 Extrinsic inputs/outputs of the hippocampus
Compared to the EC, DG granule cells receive only minor input from other cortical re-
gions. Köhler (1985) reports a variable projection from the PRE and PARA that ramifies
in the molecular layer. Subcortical inputs arise from the septal nuclei, supramammillary
area, hypothalamic nuclei, and the brain stem. The inner third of the molecular layer
receives a projection that originates exclusively from ipsilateral and contralateral neu-
rons in the polymorphic layer (mossy cells). There are no axons originating from DG
granule cells other than MF (Andersen et al., 2006; Watson et al., 2011). One prominent
extrinsic input to area CA3 neurons arises from axons of other CA3 neurons. These com-
missural/associational (c/a) inputs are numerous and originate from CA3 neurons on
both sides of the brain. CA3 neurons also have connections with cholinergic neurons in
the medial septal nucleus and the nucleus of the diagonal band of Broca, which synapse
mainly in SO. There are no backprojections from the DG or area CA3 to the EC. There-
fore, the main input region of HIP has no influence on EC activity (Andersen et al., 2006;
Watson et al., 2011). CA1 pyramidal cells receive extrinsic input via c/a fibers from the
contralateral hemisphere. Inputs from the nucleus reuniens of the thalamus and the ba-
solateral nucleus of the amygdala (AMY) innervate CA1 neurons via synapses on their
distal apical dendrites. CA1 pyramidal cells represent an important output region of the
HIP. They are heavily connected with the subiculum and layer IV/V of the EC. Via the
fimbria/fornix pathway various regions constitute targets of the CA1 principle cells (An-
dersen et al., 2006). Furthermore, there are remarkable differences in projection patterns
of hippocampal neurons depending on their specific position on the septotemporal- and
transversal axis (Amaral and Witter, 1989; Andersen et al., 2006).
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1.2 Synaptic plasticity in the hippocampus
The mammalian brain is composed of a trillion of neurons and a quadrillion of chemi-
cal synapses. This enormous connectivity gives rise to tremendously complex neuronal
networks. Electrical activity in the these networks not only shapes behavior, it also trig-
gers remarkable dynamic modifications and rewiring. The ability to respond to naturally
occurring and artificial stimulation patterns with changes in synaptic efficacy is called
synaptic plasticity (Bliss and Collingridge, 1993; Ho et al., 2011). Synaptic plasticity plays
a decisive role in the development and homeostasis of brain function. Different patterns
of stimulation elicit changes in synaptic strength on various time-scales. Here, the focus
is on long-lasting forms of cellular plasticity. Specifically, an enhancement of synaptic
response at excitatory glutamatergic synapses represents a widespread phenomenon of
experience-dependent changes in the mammalian brain (Andersen et al., 2006; Ho et al.,
2011). Synaptic plasticity is a prominent feature of hippocampal synapses, and lesions
of the HIP negatively affect the acquisition and storage of new episodic and spatial in-
formation (Neves et al., 2008), resulting in a rare unifying hypothesis in contemporary
neuroscience: "Memories might be stored by alterations in the strength of synaptic connections
between neurons in the CNS" (Byrne et al., 2008, p.296).
In 1949, the Canadian psychologist Donald Hebb formulated the first hypothesis, sug-
gesting that the acquisition and retention of new information (learning and memory)
might take place at the cellular level. He proposed that a synapse that links two neurons
is strengthened if the cells are active at the same time (Hebb, 2002, p.62). Strong experi-
mental evidence for this theory originated in 1973 by Bliss and Lømo, who were the first
to record a long-lasting enhancement of synaptic transmission in the HIP. They showed
that brief tetanic stimulations of the PP in anesthetized rabbits, induce a sustained in-
crease of the population response recorded in granule cells of the DG and titled this phe-
nomenon long-term potentiation (LTP; Bliss and Lømo, 1973. Subsequently, it has been
shown that additional forms of activity-dependent plasticity exist (e.g., long-term depres-
sion (LTD), spike timing dependent plasticity) and that synapses in the majority of brain
regions can undergo long lasting changes in synaptic response, such as the AMY, mo-
tor cortex, sensory cortex and spinal cord (Andersen et al., 2006; Bliss and Collingridge,
1993). The early studies on LTP were carried out in vivo. After the introduction of the
more feasible hippocampal slice preparation, most researchers turned towards the HIP
as a model system to study the cellular and molecular underpinnings of synaptic plastic-
ity. Specifically, a vast amount of studies was conducted on LTP at the hippocampal CA3
to CA1 synapse (CA1 LTP), resulting in a sophisticated understanding of monosynaptic
induction and expression mechanisms underlying LTP at central synapses (Andersen et
al., 2006; Byrne et al., 2008; Ho et al., 2011).
1.2.1 The role of NMDA receptors in LTP
Further experimental evidence for Hebb’s so-called "neurophysiological postulate" was
supplied by Wigström and Gustafsson (1986), showing that simultaneous presynaptic
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transmitter release and postsynaptic depolarization induce a glutamate receptor blocker
sensitive form of LTP. Consequently, it was suggested that ionotropic glutamate receptors
play a central role in the induction, expression, and maintenance of LTP at hippocampal
SC to CA1 synapses. Several different types of glutamate receptors are known and dis-
tinguished by functional and pharmacological properties, but two types - N-Methyl-D-
Aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA)
receptors are of particular interest. These receptors are ligand-gated, non-selective cation
channels that allow the flow of K+, Na+, and in some cases Ca2+ upon opening. Ac-
tivation of the AMPA receptors is triggered by the release of glutamate rendering them
permeable to K+ and Na+ and resulting in an exitatory postsynaptic potential (EPSP).
The NMDA receptor adds another dimension and subserves induction of LTP, whereas
AMPA receptors are important for its expression and maintenance. The NMDA receptor
channel pore is blocked by Mg2+ at rest. For channel opening two concomitant events
have to take place. The binding of glutamate (and the co-agonist glycine) and the relief
of the Mg2+-block by a sufficient depolarization of the postsynaptic membrane. Sub-
sequently, the channel also conducts Ca2+ ions, which can enter the postsynaptic cell.
Thereby, the NMDA channel acts as a coincidence detector, allowing a unique contri-
bution to information processing at the molecular level, in a manner analogous to the
model proposed by Hebb (2002) for associative learning (Bliss and Collingridge, 1993;
Byrne et al., 2008; Ho et al., 2011; Wigström and Gustafsson, 1986). Out of several types of
LTP which have been reported so far, the best understood is NMDA receptor-dependent
LTP, that received its name because D-APV (see Appendix 8.1) and MK-801, two highly
specific antagonist of the NMDA receptor, block its induction while having almost no
effect on basic synaptic transmission. The discovery by Morris et al. (1986) that D-APV
injected into rodent HIP severely impairs spatial memory acquisition, and two recent
studies reporting LTP-like synaptic changes in the HIP following learning support the
necessity of LTP for information storage (Gruart et al., 2006; Morris et al., 1986; Whitlock
et al., 2006).
The Ca2+ entrance into the postsynaptic compartment through NMDA receptors seems
to be an absolutely necessary trigger for the induction of NMDA receptor-dependent LTP
(Malenka and Bear, 2004). The intracellular Ca2+ concentration is tightly regulated with
very low intracellular (0,0002 mM) and relatively high extracellular (2 mM) concentra-
tions, whereby small changes trigger profound alterations in intracellular signaling. First
evidence that Ca2+ is a central mediator connecting extracellular events with intracellu-
lar signaling cascades came from Lynch et al. (1983). They injected the calcium chela-
tor ethyleneglycol-bis-(-aminoethylether)-N,N,N’,N’,-tetraacetic acid, into CA1 pyrami-
dal cells and thereby blocked the induction of CA1 LTP. Moreover, Malenka et al. (1988)
showed that chemically induced release of Ca2+ in the postsynaptic cell is sufficient to
induce CA1 LTP. Several postsynaptic mechanisms involved in the expression and main-
tenance of CA1 LTP have been identified so far and following several decades of con-
troversy the contribution of presynaptic changes and glia cells are now considered to be
essential partners (Ho et al., 2011; Malenka and Bear, 2004). The Ca2+-dependent AMPA
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trafficking at the postsynaptic plasma membrane (by lateral diffusion and exocytosis; re-
moval by endocytosis) and activation of postsynaptic kinases (e.g., calcium/calmodulin-
dependent protein kinase II) and phosphatases (e.g., protein phosphatase 1) are believed
to regulate downstream targets important for LTP expression and maintenance (Byrne et
al., 2008; Ho et al., 2011).
1.2.2 Hippocampal plasticity during theta oscillations
Comparable to the situation in the EC, theta oscillations (3-10 Hz) represent a promi-
nent network pattern in the HIP of mammals and are often associated with the formation
of episodic and spatial memories (Axmacher et al., 2006; Berry and Thompson, 1978;
Buzsàki, 2002; Rutishauser et al., 2010; Winson, 1978). The extracellular currents un-
derlying theta oscillations are believed to be mainly of extrinsic origin, generated by
an interplay between inhibitory (medial septum) and excitatory (via PP) inputs (Pernía-
Andrade and Jonas, 2014; Buzsàki, 2002). However, recent evidence suggests that sev-
eral intrinsic theta generators exist in area CA1 (Goutagny et al., 2009). Many cells in
the HIP exhibit a rhythmical pattern of firing that is related to theta, and the onset of
stimuli causes ongoing theta to reset so that it becomes phase-locked to the stimuli (Mc-
Cartney et al., 2004). Therefore, theta-frequency oscillations might provide a framework
how sequential binding of cell assemblies over a temporal metric brings about synap-
tic modification (Goutagny et al., 2009; Hasselmo, 2005). The most prominent theta
oscillations are observed in CA1 and the relationship between discharge of pyramidal
cells and fluctuations in membrane potentials are best understood. Several studies re-
port that the induction of LTP is optimal when several high-frequency pulses were ap-
plied every 200ms (theta-burst stimulation). Moreover, stimulations at specific phases
of the theta cycle induce distinct effects. Activation on the peak of theta, recorded lo-
cally in stratum radiatum of CA1, causes LTP, while stimulation on the trough causes
LTD. This seems to depend on phasic changes in pyramidal cell depolarization during
theta rhythm, priming them for synaptic plasticity (Buzsàki, 2002; Capocchi et al., 1992;
Hasselmo, 2005; Stäubli and Lynch, 1987). Interestingly, single hippocampal neurons in
freely behaving rats fire normally at the peak of ongoing theta activity (McCartney et
al., 2004). Furthermore, several lines of evidence suggest that synchronization of theta
activities between HIP and other brain regions (AMY, prefrontal cortex (PFC)) improves
neuronal communication during region specific memory tasks (Seidenbecher et al., 2003;
Siapas et al., 2005).
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1.3 Neurocircuitry of stress
Homeostasis and, thus, survival of all organisms is permanently challenged by physio-
logical (systemic) and emotional (neurogenic, psychogenic) adverse effects, termed stres-
sors. Physiological stressors like hypoxia or hemorrhage are believed to exceed selec-
tive homeostatic systems. In contrast, emotional stressors require an anticipatory re-
sponse that is initiated by comparison of the stimuli with innate programs or memo-
ries (Chrousos, 2009; de Kloet et al., 2005; Jankord and Herman, 2008). Such an antic-
ipatory response likely involves several highly intersected limbic brain structures (e.g.,
HIP, AMY, PFC), rendering the response greatly influenced by the organism’s ability
to predict and control the presence or intensity of the stressor. Consequently, the indi-
vidual’s appraisal and coping strategy is highly variable (Jankord and Herman, 2008;
Kim and Diamond, 2002). When stress is overwhelming or perceived to be so, a cas-
cade of neuroendocrine adaptive responses is initiated to re-establish homeostasis (de
Kloet et al., 2005; McEwen, 2007; Raison and Miller, 2003). Adaptive responses en-
gage the so-called stress system which is situated in the central nervous system (e.g.,
hypothalmaus, pituitary, spinal cord) and in several peripheral organs (e.g., adrenals,
liver), mediating a fast and relatively stereotopic response to maintain physiological
integrity even in life threatening situations (Figure 1.2; Ulrich-Lai and Herman, 2009).
Next to the autonomic nervous system, which engages very rapid alterations in phys-
iological functions, the hypothalamic-pituitary-adrenal (HPA) axis constitutes a central
hub in the neurocircuitry of stress, orchestrating an appropriate regulatory response ac-
cording to the characteristics and physiological impact of the stressor (Chrousos, 2009;
de Kloet et al., 2005; Radley, 2012). Upon activation, which is reflected by a peripheral
release of steroid hormones (SH), including glucocorticoids (GC), but also the local re-
lease of neurotransmitters (e.g., glutamate, noradrenaline, serotonine) and neuropeptides
(corticotropin releasing hormone (CRH), adrenocorticotropic hormone (ACTH)), a wide
array of organ systems is activated and integrated by central and peripheral feedback
to the brain (Figure 1.2; de Kloet et al., 2005; Joëls et al., 2009; Maras and Baram, 2012;
McEwen, 2007). Beyond rapid activation of the HPA axis for adaptive coping, there exists
substantial evidence that excessive or prolonged activation damages brain structures (es-
pecially the HIP; Figure 1.3). The resultant excess in stress hormones is widely implicated
in the onset of SRPDs (Chrousos and Gold, 1992; de Kloet et al., 2005; Holsboer, 2000;
Radley, 2012).
1.3.1 Activation of the HPA axis
Endocrine systems are constantly active to maintain the integrity of the organisms home-
ostasis. However, intense excitation of the HPA axis occurs in response to any external or
internal challenge that overwhelms the individual’s ability to adapt and cope. Physiolog-
ical stimuli engage regulatory processes by ascending brainstem systems or circumven-
tricular organs (visceral and sensory stimuli) projecting directly to the parvocellular di-
visions of the paraventricular nucleus of the hypothalamus (PVN), whereas psychogenic
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stimuli, mediated by the limbic system, converge indirectly onto this structure (McEwen
and Gianaros, 2011; Popoli et al., 2012).
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Fig. 1.2. Schematic illustration of the HPA axis. In re-
sponse to stress, CRH is released into hypophysial por-
tal vessels by neurons localized in the PVN of the hy-
pothalamus. CRH subsequently cause ACTH release
from the anterior pituitary. ACTH stimulates SH pro-
duction in the adrenals and secretion into the systemic
circulation. SHs, including CORT modulate several tar-
gets and inhibit further HPA axis activation via MRs and
GRs, that are widely distributed throughout the brain
(modified from Myers et al., 2012).
Upon activation, parvocellular neurons
produce CRH. Together with simulta-
neously released arginine vasopressine,
CRH induces the release of ACTH from
the pituitary gland via the portal circu-
lation. ACTH enters the blood stream
and triggers the release of SHs from the
zona fasciculata of the adrenal glands.
Among these, GCs (cortisol in humans
and corticosterone (CORT) in rodents)
are often associated with SRPDs (Figure
1.2; Jankord and Herman, 2008; Smith
and Vale, 2006).
GCs readily overcome the blood brain
barrier and bind to two types of re-
ceptors, the mineralocorticoid receptor
(MR) and the glucocorticoid receptor
(GR). These receptors are ligand driven
transcription factors. Most of them re-
side in the cytoplasm and binding of cor-
ticosteroids triggers translocation of the
receptor complex to the nucleus. Here,
the SH receptor complex changes gene
transcription directly through binding to
recognition sites in the DNA or indi-
rectly via interactions with other tran-
scription factors. The MR is highly ex-
pressed in limbic brain areas and has
a approximately tenfold higher affinity
to GCs than the GR. This high affinity
renders the MR activated, even through
the absence of stress. A common the-
ory is that the MR is important for basal
GC tone and stress response initiation,
whereas the more ubiquitously expressed GR (except for area CA3) is only activated
by large amounts of GCs, pointing to a more reactive role in stress response including
the termination of HPA axis activation (de Kloet et al., 2008; Groeneweg et al., 2011;
Karst et al., 2005).
Recent evidence suggests the existence of an additional family of membrane bound
MRs and GRs that are coupled to G-protein-coupled receptors (GPCRs), exerting rapid
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effects on the excitability and activation of neurons via nongenomic pathways. De-
spite their different location, these receptors are known to differ by their molecular
structure, their affinities to CORT, and their mode of action (Groeneweg et al., 2011;
Maggio and Segal, 2010). This is thought to partially explain the observation of a fast
and delayed feedback inhibition of the HPA axis by circulating GCs. This regulation
likely occurs via GRs and MRs, expressed in structures of the HPA axis (PVN, pituitary)
or indirectly via GRs or MRs, expressed in brain regions with afferent connections (direct
or indirect) onto PVN neurons (HIP, AMY, PFC; Figure 1.2; Jankord and Herman, 2008;
Smith and Vale, 2006).
Beside SHs, CRH has been increasingly recognized to mediate stress-induced alterations
in the HIP. It is now well established that several brain regions contain CRH-expressing
neurons, including the HIP (Maras and Baram, 2012). Its release upon stress constitutes
the starting point of HPA axis activation, and the neuropeptide modulates diverse brain
functions via two GPCRs: CRH receptor types 1 (CRHR1) and 2 (CRHR2). Especially
CRH-CRHR1 interaction seems to be important in the modulation of neuronal excitabil-
ity of hippocampal neurons. The receptor is expressed on neurons in all subfields of the
HIP but most abundant on the somata and dendrites of CA1 pyramidal cells, which is
consistent with its proposed modulation of glutamatergic signaling and synaptic plastic-
ity. The mechanisms by which CRH modulates synaptic plasticity have been shown to be
highly dose- and time-dependent, however, knowledge about the underlying molecular
and cellular mechanisms is still sparse (for overview see Maras and Baram, 2012).
Overall, peripherally and centrally released SHs mediate complex acute and chronic ef-
fects throughout the body including the brain. Locally released neurotransmitters and
neuropeptides provide a spatially restricted modulation of hippocampal physiology and
actions within a time frame of milliseconds. Furthermore, stress mediators are not se-
creted to the same amount throughout the day. For example, stress triggers the release
of large bursts of GCs, which are superimposed on a basal pulsatile and circadian secre-
tion mode. These diverse functions of HPA axis-related hormones and transmitters along
a continuum of spatial and temporal domains illustrate the complex interplay between
stress, mediators of the stress system and hippocampal physiology (Figure 1.2; Joëls et
al., 2009; Maras and Baram, 2012).
1.3.1.1 Role of the hippocampus in stress integration
Multifarious afferent projections modulate neurons in the PVN. Major projections arise
from four distinct brain regions: brain stem neurons, cell groups of the lamina terminalis,
extra-hypothalamic nuclei, and forebrain limbic structures (HIP, AMY, PFC). Not all of
these cell groups provide direct innervation of the PVN. However, information from a
wide array of sensory modalities converge onto PVN neurons, influencing expression
and release of CRH from parvocellular neurons (Radley, 2012; Smith and Vale, 2006).
The HF has been implicated as a key contributor in the inhibitory regulation of the HPA
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axis and in the termination of the stress response. After chronic stress, there is a remark-
able downregulation of GC receptors on hippocampal neurons. Forebrain specific down-
regulation of GC receptors causes an increase of basal CORT secretion and a resistance
to the dexamethasone-mediated, negative feedback inhibition of the HPA axis. Further-
more, lesions in the HIP under basal conditions and following stress disrupt the circa-
dian GC rhythm and produce elevated basal levels of circulating mediators of the HPA
axis. These lesion experiments also showed that the response to particular stressors was
changed. The reaction to physiological stressors remains largely unaffected, while the re-
sponse to emotional stressors (e.g., restraint, open field) was prolonged, indicating a spe-
cific role for stimulus modality. In turn, stimulation of hippocampal neurons in vivo re-
duces ACTH and CORT release (Jankord and Herman, 2008; Herman and Mueller, 2006;
Radley, 2012; Roozendaal et al., 2001; Smith and Vale, 2006).
Nevertheless, the HIP possesses no direct connections with CRH producing neurons
in the hypothalamus. But how does the predominant excitatory glutamatergic projec-
tion from the HIP (specifically ventral subiculum) exerts inhibitory drive onto the HPA
axis? The transformation is thought to be mediated by disynaptic projections to other
brain regions with direct projections onto parvocellular neurons, like the infralimbic
cortex and the anterior bed nucleus of the stria terminalis. The latter renders excita-
tory output from the HIP inhibitory, likely contributing to the fast GC-mediated feed-
back inhibition of the HPA axis. Interestingly, hyperactivity and loss of negative feed-
back occur in more than 50% of depressed patients (Figure 1.2; de Kloet et al., 2005;
Duman and Aghajanian, 2012; Jankord and Herman, 2008; Herman and Mueller, 2006;
Radley, 2012; Smith and Vale, 2006; Tasker et al., 2006).
1.3.2 Effects of stress in the hippocampus
Studies performed in the human and animal HIP have revealed various mechanisms
how acute and chronic stress exposure alters hippocampal function, including: (i) Molec-
ular alterations: e.g., enhanced glutamate and GC release, decreased expression of neu-
rotrophins; (ii) cellular effects: e.g., enhanced cell loss and neuronal atrophy, decreased
synaptic plasticity; (iii) morphological changes: e.g., decreased hippocampal volume, al-
tered neuronal network connectivity. Initial molecular and cellular effects of stress can
progress to severe structural modifications of neurons of the HIP and other limbic brain
regions. On longer timescales, these molecular and cellular refinements can lead to mor-
phological changes, characterized by deficiencies in neuronal function and neuronal net-
work connectivity (Figure 1.3; Duric and Duman, 2013; Kim and Diamond, 2002; Maras
and Baram, 2012; Radley, 2012; Sousa et al., 2000). Acute stress and low to moderate rises
in CORT levels in the HIP are paralleled by enhanced neurotransmission, likely mediated
by nongenomic pathways upon activation of membrane bound MRs. The best under-
stood mechanism is a rise of extracellular glutamate levels, causing a rapid and reversible
enhancement of miniature excitatory postsynaptic current frequency in area CA1, accom-
panied by an increased probability of postsynaptic action potential induction (Joëls, 2006;
Karst and Joëls, 2005; Popoli et al., 2012; Sandi, 2011).
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Fig. 1.3. Stress and ADs bidirectionally modulate hippocampal physiology. Diverse molecular, cellular
and morphological modifications in the HIP are driven by stress and AD treatment in a time-dependent
manner (modified from Duric and Duman, 2013).
The effects of chronic stress and high levels of CORT on basal neurotransmisson in the
HIP are less well understood. Basal glutamate release seems to be unaffected, but synap-
tic plasticity is profoundly impaired (Popoli et al., 2012). First experimental evidence
came from Foy et al. (1987), showing that adult rats receiving restraint tailshock stress
exert marked impairments of CA1 LTP in vitro. Comparable effects on LTP induction
were obtained with administration of high doses of CORT in vivo and in vitro (Maggio
and Segal, 2010). Subsequent studies revealed a link to the HPA axis, showing that LTP
impairment after acute inescapable stress is prevented by GR blockers and protein syn-
thesis anatagonists (Xu et al., 1997; Xu et al., 1998).
The effects of CRH reported from in vitro and in vivo experiments in the HIP mostly re-
semble the effects of CORT. Acute stress and low concentration of CRH enhance neuronal
excitability and potentiate synaptic plasticity, whereas chronic stress and high CRH con-
centrations exert opposing effects (Maras and Baram, 2012; von Wolff et al., 2011).
Today, it is well established that stress has strong effects on synaptic transmission and
synaptic plasticity in the HIP, including a dose-dependent relationship between CORT
concentration and cellular effects. The often proposed inverted U-shaped relationship
of circulating GCs on cellular functions is likely accomplished by differential activation
(time, concentration) of co-expressed GRs and MRs in the HIP (de Kloet et al., 2005;
Diamond et al., 1992; Joëls, 2006; Joëls et al., 2009; Maggio and Segal, 2010).
Overall, the two co-existing roles of the HIP - learning and memory, and regulation of
HPA axis activity - seem to be dramatically affected by stress. In addition, chronic stress
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triggers a reorganization of the stress control circuitry (Ulrich-Lai and Herman, 2009).
On this basis, Sapolsky et al. (1986) formulated the "glucocorticoid cascade hypothesis"
of hippocampal aging, outlining that a damage of brain structures important to HPA axis
restraint engage a feed forward circuit enabling ongoing stressors to render GC over-
production indefinitely. Dysfunction of neuronal excitability and synaptic plasticity may
aggravate this "viscious circle" by preventing an individual’s ability to adapt to new situa-
tions and to make decisions about how to deal with new challenges or stressors (McEwen
and Gianaros, 2011; Raison and Miller, 2003; Sapolsky et al., 1986).
1.4 Pharmacology of antidepressants
Although SRPDs cause severe individual and socioeconomic burden, current pharma-
cological therapies remain unsatisfactory, requiring several weeks of administration to
produce a clinical benefit, while leaving a demanding amount of patients resistant to
drug treatment. Furthermore, the cellular processes underlying therapeutic effects of
ADs remain elusive (Duman and Aghajanian, 2012; Krishnan and Nestler, 2008). Nev-
ertheless, ADs are the first-line medication to counterbalance the detrimental effects of
SRPDs (Olfson and Marcus, 2009; Pratt et al., 2011). It was reported that the rate of pre-
scribed medication in the United States of America (USA) increased from 5.84% in 1996
to 10.12% in 2005 with a concomitant decreased likelihood of patients to undergo psy-
chotherapy (Olfson and Marcus, 2009). Based on this study and findings from the USA
Health and Nutrition Examination Surveys (2005-2008) (Pratt et al., 2011), it was esti-
mated that 11% (27 million people) of the US American population older than 12 took
AD medication between 2005 and 2008 (Olfson and Marcus, 2009; Pratt et al., 2011).
1.4.1 Classification of antidepressants
The serendipitous discovery of the first ADs resulted from clinical observations in the
1960s. Iproniazid and imipramine, two non-psychiatric drugs, exert potent antidepres-
sant effects in humans, and a more detailed examination revealed that they enhance
synaptic serotonin and noradrenaline transmission (Berton and Nestler, 2006; Krishnan
and Nestler, 2008). On that template, various compounds with AD properties were de-
veloped, rendering the group of AD drugs quite heterogeneous. In contrast, these drugs
are characterized by only a few known functional effects, that are possibly associated
with their therapeutic efficiency. Therefore, their classification based on functional char-
acteristics might be more useful than a structural one (Richelson, 2001).
The first group of drugs inhibits the reuptake of monoamines by blocking the seroto-
nine transporter (SERT), norepinephrine transporter (NET), and dopamine transporter
nonspecifically (tricyclic antidepressants (TCA) e.g., amitriptyline or clomipramine; Kr-
ishnan and Nestler, 2008; López-Muñoz and Alamo, 2009; Wrobel, 2007).
The second group of drugs block the destruction of monoamine neurotransmitters by the
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enzyme monoamine-oxidase (MAO) (monoamine-oxidase inhibitor (MAOI), e.g., tranyl-
cypromine, isocarboxazid). Two isoforms of MAO exist: MAO-A / MAO-B and this
group can be further subdivided depending on whether the blockade is isoform-selective
and reversible or not (Yamada and Yasuhara, 2004).
With the introduction of fluoxetine in 1988 (Wrobel, 2007), the well established "first-
generation" ADs have been extended by a third group, the so-called "second-generation"
ADs which are characterized by a more specific inhibition of SERT and NET. Accord-
ing to their effects on specific transporters, they are further classified into distinct groups.
These include ADs selective for serotonine (selective serotonine reuptake inhibitor (SSRI)
(e.g., fluoxetine, citalopram), noradrenaline (selective noradrenaline reuptake inhibitor
(SNRI) (e.g., desipramine, reboxetine) or a combination of both (selective serotonine no-
radrenaline reuptake inhibitor (SSNRI); e.g., venlafaxine, duloxetine; Berton and Nestler,
2006; López-Muñoz and Alamo, 2009; Wrobel, 2007).
The actual selection of specific ADs for a patient depends on various factors includ-
ing the patient’s prior experience with medication, actual symptoms and medication,
severeness of disease, etiopathology, receptor affinity of the drug, comorbidity, genetic
polymorphisms in stress-related genes, age and adverse side effects (Bauer et al., 2007;
Binder et al., 2004; Richelson, 2001). The latter are predominantly caused by a rela-
tively high affinity of most ADs to biogenic amine-receptors (α1-adrenergic, dopamine
D2, histamine H1, muscarinergic acetylcholine and 5-HT2a), mediating symptoms like
dry mouth, sweating, sedation, sexual dysfunction, orthostatic hypotension or weight
gain. Unfortunately, the adverse side effects usually occur more rapidly than beneficial
ones, a fact that is often considered as the leading cause for the low compliance seen
in patients under AD medication (Bauer et al., 2007; Binder et al., 2004; Bylund, 2007;
Richelson, 2001).
Overall, meta-analyses failed to reveal substantial differences in efficacy between first-
and second-generation ADs, rendering the latter ones lower affinity to the biogenic amine
receptors the possible advantage over first-generation ADs (Anderson, 2000; Cipriani et
al., 2009; Gartlehner et al., 2011; Richelson, 2001; Schatzberg, 2002).
1.4.2 Theories of antidepressant drug action
The discovery that iproniazid (MAOI) and imipramine (TCA) target monoamine neuro-
transmission set the foundation of the so-called catecholamine and serotonin hypotheses
of depression (Berton and Nestler, 2006; Holsboer, 2000). It was postulated that altered
production, release, turnover or function of monoamine neurotransmitters (especially
serotonin (5-hydroxitryptamine or 5-HT) and norepinephrine) or altered function of their
GPCRs (except serotonin 5-HT3 receptor; Millan et al., 2008) in certain brain areas might
underlie depression, and that ADs are able to reverse the underlying synaptic deficit
(Foord et al., 2005; Holsboer, 2000; Luscher et al., 2011; López-Muñoz and Alamo, 2009;
Nutt, 2002). This was a tremendous advantage in neuropsychopharmacology, equip-
ping researchers and physicians with a cellular correlate for depression and other SRPDs
for the first time. However the drawback is that research has been canalized onto this
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particular neurotransmitter system, hampering research on non-monoamine-based ADs
(Berton and Nestler, 2006; López-Muñoz and Alamo, 2009). After the development of
more selective compounds for the noradrenergic- (e.g., desipramine, SNRI), and the sero-
tonergic system (e.g., clomipramine, SSRI), drugs that are selective for two monoamine
transporters were developed (e.g., venlafaxine). Although there was a lack of clinical ev-
idence, it has been suggested that balanced or dual reuptake inhibitors may be superior
to single re-uptake inhibitors (Berton and Nestler, 2006; López-Muñoz and Alamo, 2009;
Wrobel, 2007).
However, the monoamine hypothesis is challenged by several inherent inconsistencies,
the main one being the delayed onset of the clinical AD effect (several weeks) of most
drugs, although monoamine reuptake inhibition occurs immediately following drug ad-
ministration (due to Ki values in the low nanomolar range), and the finding that sev-
eral cellular processes assumed to be important for ADs efficiency, are activated rapidly
(Berton and Nestler, 2006; Holsboer et al., 2012; Holsboer, 2000; Krishnan and Nestler,
2008; Rantamäki et al., 2011). Furthermore, tianeptine, a selective serotonine reuptake
enhancer (SSRE) exerts AD effects (McEwen et al., 2010; Sanacora et al., 2012). Complicat-
ing the picture, dietary tryptophan, which diminishes serotonin levels in the brain, does
not significantly affect mood in healthy volunteers and patients suffering from MD (Cas-
trén, 2005). Moreover, by means of various methodological approaches, including genet-
ically altered mice which display depression-related behavior (Cryan et al., 2002), vari-
ous mechanisms of AD drug action have been identified so far. This includes the afore-
mentioned monoaminergic system, the glutamatergic system, the GABAergic system, ion
channels, neurotrophins like brain-derived neurotrophic factor (BDNF), and components
of the HPA axis. Several of these targets are modulated by AD drug concentrations much
higher than those required for serotonin/norepinephrine reuptake inhibition, support-
ing the idea of monoaminergic-independent effects occurring with brain concentrations
of ADs in the high nanomolar/low micromolar range (Duman and Aghajanian, 2012;
Holsboer and Barden, 1996; Jang et al., 2009; López-Muñoz and Alamo, 2009; Luscher et
al., 2011; Méndez et al., 2012; Rammes and Rupprecht, 2007; Saarelainen et al., 2003). In
line with this, magnetic resonance spectroscopy studies in humans revealed fluoxetine
and fluvoxamine brain concentrations in the low micromolar range after a few weeks of
drug administration. Interestingly, the appearance of such concentrations match with the
time point of symptom alleviation (Bolo et al., 2000; Strauss et al., 1997).
These observations point to cellular adaptions and morphological changes triggered by
ADs far from a simple increase of the synaptic availability of monoamines. Additional
changes in intracellular signal transduction cascades and synaptic connectivity are likely
to occur (Castrén, 2005; López-Muñoz and Alamo, 2009). Accordingly an alternative
hypothesis to the chemical view of SRPDs and the action of ADs has emerged in re-
cent years (Castrén, 2005; Leistedt and Linkowski, 2013). The network hypothesis argues
that information processing disturbance within distinct neuronal networks represents the
common final pathway of SRPDs and that AD drugs induce changes in neuronal plas-
ticity and connectivity that, when treated chronically, gradually lead to improvements in
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neuronal information processing and healing of the disorder (Figure 1.3; Castrén, 2005).
However, contradicting evidence comes from the observation that AD medication has
often to be taken for several years and a termination of drug intake after symptom al-
leviation leads to a relapse to disease in a high percentage of patients (Castrén, 2005;
Leistedt and Linkowski, 2013; Castrén, 2013). Nevertheless, an increasing amount of data
highlights the effects of ADs on the plasticity of neuronal networks. Imaging studies in
patients with MD have revealed that reduced gray matter in the HIP is to some degree
reversed by ADs (Castrén, 2005). Highly recognized evidence for the network hypothesis
comes from the observation that chronic stress decreases and ADs increase the produc-
tion and/or turnover of new neurons in the rodent HIP (Castrén, 2005; Duric and Duman,
2013). Interestingly, the increased neurogenesis facilitated by chronic AD treatment coin-
cidences with the behavioral effects produced by ADs. It is thought that ADs restore or
facilitate synaptic plasticity, reminiscent to the situation during development and thereby
alleviate adaptions in neuronal connectivity (Castrén, 2005; Leistedt and Linkowski, 2013;
Maya Vetencourt et al., 2008).
1.4.2.1 Role of neurotrophic factors and their receptors in the pharmacology of an-
tidepressants
Neurotrophins, which include nerve growth factor (NGF), BDNF, NT-3, NT-4/5, and
NT-6 are critical regulators of the formation and plasticity of neuronal networks and
are produced in an activity-dependent manner (Castrén et al., 2007; Jang et al., 2009;
Poo, 2001). The physiological actions of neurotrophins are mediated through two classes
of receptors: high-affinity tyrosine related kinase (Trk) receptors and a low-affinity pan-
neurotrophin-receptor (p75NTR). The Trk receptors are members of a transmembrane
tyrosine kinase family (TrkA, TrkB, and TrkC). NGF predominantly binds and activates
TrkA, BDNF, and NT-4/5 mainly interact with TrkB, and NT-3 predominantly associates
with TrkC, while having lower affinity to TrkA and TrkB receptors. Binding of neu-
rotrophins to Trk receptors initiates receptor homodimerization, autophosphorylation of
cytoplasmic tyrosine residues on the receptors, and a cascade of cell signaling events in-
cluding Ras/Raf/MAP kinase, PI3K/Akt, and PLC-γ1 (Jang et al., 2009; Poo, 2001). In
addition to long-term effects of neurotrophins like gene regulation, the cytoplasmic ef-
fectors activated by neurotrophins have been also implicated in a wide range of more
rapid actions, most notably modulation of neuronal excitability and synaptic transmis-
sion (Berton and Nestler, 2006; Poo, 2001). Chronic stress is widely used as a model of
SRPDs. Chronic stress decreases expression of BDNF in the HIP of rodents and a common
finding is, if administered chronically but also acutely, most ADs induce autophospho-
rylation of TrkB receptors in the HIP, which is sufficient to ameliorate the detrimental
effects of stress on behavior (Berton and Nestler, 2006; Poo, 2001; Saarelainen et al., 2003).
Moreover, reduced levels of BDNF have been found in patients suffering from MD and
AD drug therapy restores brain BDNF levels to the normal range (Castrén et al., 2007).
However, it is important to note that BDNF and other neurotrophic factors do not con-
trol mood and no single hypothesis of AD action is valid by oneself (Castrén, 2005;
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Leistedt and Linkowski, 2013). Rather, the different adaptive system seem to be orches-
trated in response to AD treatment. The synthesis and release of several important neu-
romodulators and neurotransmitters is regulated by neuronal activity and changes in
activity patterns produce changes in the concentrations of these signaling molecules. Al-
though the initial effects of ADs are obviously chemical, subsequent adaptive changes
in the concentrations of these signaling molecules are tightly linked to the structure of
neuronal networks and may be a consequence of altered information processing rather
than its cause (Leistedt and Linkowski, 2013). According to this view, it is more likely
that AD treatment rapidly modulates several molecular and cellular targets, which acti-
vate neurotrophic factor systems, thereby re-establishing normal activity patterns in the
hippocampal neurocircuitry and ultimately in behavior (Figure 1.3; Castrén et al., 2007;
Duman and Aghajanian, 2012). Therefore, analyzing endophenotypes of specific brain
circuits might help bridging the gap between molecular/cellular processes and behav-
ioral outcome under AD treatment.
Chapter 2
Aims of the thesis
Extensive research in humans and rodents has shown that cognitive deficits and a distur-
bance of the neuroendocrine stress response are frequently associated with stress-related
psychiatric disorders (SRPDs), but also provided substantial evidence that these symp-
toms are likely mediated by malfunction of information processing within distinct neu-
ronal networks, including the hippocampus (HIP; Airan et al., 2007; Castrén, 2005).
Classical electrophysiology has gained valuable insights regarding the contribution of
single cells and small neuronal populations in the pathophysiology of SRPDs. How-
ever, this "sparse world view" provides a limited and possibly distorted picture of how
large-scale neuronal networks respond to a constantly changing environment in real time
(Lewis and Lazar, 2013). Accordingly, a more intensive use of circuit-centered approaches
in psychiatric research is highly recommended (Karayiorgou et al., 2012). Within this
framework, the present dissertation intended to address three major questions:
1. First, which activity pattern in perforant path fibers is capable of evoking polysy-
naptic activity flow through the HIP in vitro?
2. Second, is this circuit-centered approach suited to address a long standing question
in hippocampal physiology: How do brain systems afferent to the HIP initiate the
formation of CA1 LTP?
3. Third, is this circuit-centered approach suited to investigate whether and how chronic
stress and acute application of various drugs alter neuronal network dynamics in
the HIP?
To address these questions, field potential recordings and voltage-sensitive dye imaging
(VSDI) were applied to mouse brain slices. VSDI allows the analysis of neuronal ac-
tivity on a millisecond time-scale, with a micrometer-range spatial resolution and, most
notably, a scope spanning the entire HIP (Airan et al., 2007; von Wolff et al., 2011).
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Material and Methods
3.1 Animals
CD1 male breeders (12-24 week-old, Charles River; Erkrath; Germany) were used as "res-
ident" mice within the chronic social defeat stress (CSDS) paradigm. All other animals
comprise adult (8-12 week-old) male C57BL/6N mice (MPI of Neurobiology; Martins-
ried; Germany). Animals that underwent the CSDS paradigm were single-housed, all
other mice were housed one to five per standard cage (25 x 19 cm) at the animal facility
of the Max Planck Insitute of Psychiatry (MPIP) in Munich. The animals received food
and water ad libitum and temperature and humidity were maintained constant (22 ◦C ±
1 ◦C; relative humidity 55%± 10%) with a 12 h light/dark cycle (lights on from 7:00 A.M.
to 7:00 P.M.). All experimental procedures were approved by the Committee of Animal
Health and Care of the local governmental body and were performed in strict compli-
ance with the guidelines for the care and use of laboratory animals set by the European
Community.
3.1.1 Chronic social defeat stress paradigm
The CSDS paradigm was carried out by Andre´s Uribe (RG M.V. Schmidt) at the MPIP.
In brief, male CD1 mice served as resident mice, which were held under the conditions
described above. They were allowed to habituate to a standard cage for 1 week and
afterwards to the social defeat cage (45 cm x 25 cm) for 5 to 7 days prior to the experiment.
For the CSDS, an experimental C57BL/6N mouse was placed into the defeat cage of a
physically superior resident CD1 mouse for approximately 1 min. During this period
the C57BL/6N mouse was physically defeated by the CD1 mouse. The physical contact
was carried out between 9 a.m. and 5 p.m. in a random manner to avoid habituation to
a fixed schedule of defeat. After physical interaction, the CD1 and experimental mouse
were maintained in sensory contact for 24h, using a perforated metal partition dividing
the defeat cage in two. The experimental mice were exposed to an unfamiliar CD1 mouse
defeat cage for 19 consecutive days and VSDI recordings were conducted between day
15 to 20. On the day of data acquisition the animals were not exposed to a CD1 mouse.
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All mice were handled daily, and weight and fur status was assessed. Injured animals
were discarded from the experiments (Berton et al., 2006; Wang et al., 2011).
3.2 Preparation and staining of brain slices
Initial experiments revealed that brain slice quality is paramount for optical recordings of
polysynaptic activity flow in the HIP. Thus, the most crucial steps of brain slice prepara-
tion are described in detail. The brain should be removed rapidly from the cranium, but
handled as gently as possible to avoid damage. Mice were anesthetized with isoflurane
(see Appendix 8.1) and decapitated at the level of the cervical spinal cord using an animal
guillotine. All following steps were done in ice-cold sucrose-based saline (Bischofberger
et al., 2006). The fractionally frozen physiological saline was crushed with a hand blander
to a homogenizate, thereby avoiding damage of the brain by ice crystals or concentration
gradients. The saline (pH 7.4) was saturated with carbogen gas (95% O2/5% CO2) us-
ing microfilter candles and consisted of (in mM): 87 NaCl, 2.5 KCl, 25 NaHCO3, 1.25
NaH2PO4, 0.5 CaCl2, 7 MgCl2, 25 glucose, and 75 sucrose. After decapitation, the brain
was transferred into a petri dish and the brain was rapidly removed from the cranial
cavity including the following steps:
1. Removal of the scalp by a sagittal incision from caudal to frontal
2. Sagittal incision (median) of the cranium, beginning at the level of the foramen
magnum to frontal
3. Two small incisions on each side of the cranium perpendicular to the previous one
at the level of bregma
4. Swinging open the skull on each side with a butt forceps
5. Gentle removal of the brain from the cranial cavity from frontal to caudal with a
slim spatulum
6. Transfer of the brain with a flat spatulum for storage in carbogenated cutting solu-
tion (30sec.).
Next, the brain was separated into its hemispheres and the right hemisphere was pre-
pared for the slicing procedure by a special transversal cut, which is sometimes called
"magic cut" (Bischofberger et al., 2006). These cuts were done on a standard filter paper
to simplify the cutting procedure. Cutting the hemisphere at this specific angle optimizes
the conservation of the intrahippocampal axonal projections along its septotemporal axis
(Bischofberger et al., 2006). To remove excessive saline, a standard filter paper was used.
Accordingly, the brain was glued at the "magic cut" side on the cooled tissue block with a
tissue adhesive produced from enbucrilate (Histoacryl R©; Aesculap AG; Tuttlingen; Ger-
many). As soon as the hemisphere adhered to the tissue block, a few drops of ice-cold
saline were dripped onto the brain with a pipette. This avoids that glue creeps up, covers
the surface of the brain and aggravates the movement of the razor blade (Bischofberger
et al., 2006). Then the tissue block was immediately placed in the cutting dish of the
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vibratome (HM650V, Freq.: 66, Ampl.: 0.9, V=8; Thermo Scientific; Waltham; USA). Sub-
sequently, 350 µm-thick horizontal slices containing the HIP were cut with a cleaned
(acetone, ethanol) razor blade (Dreaming; Goldhand mbH; Düsseldorf; Germany). Ac-
cording to Bischofberger et al. (2006), the angle between blade and horizontal plane was
set at ∼ 17 ◦. When the respective slice was cut, the vibratome was stopped and the
slice was removed with a needle by two cuts perpendicular to each other through the
surrounding tissue. Afterwards, slices were transferred into a maintenance chamber,
where they were placed upside-down in contrast to the original orientation during the
slicing procedure. This orientation should be maintained through all following steps
until the end of VSDI measurements. After preparation, slices were incubated in carbo-
genated sucrose-based saline for 30 min at 34 ◦C. Subsequent staining of slices with the
voltage-sensitive dye Di-4-ANEPPS (see 8.1; Tominaga et al., 2000; Airan et al., 2007; Re-
fojo et al., 2011; von Wolff et al., 2011), dissolved in dimethyl sulfoxide (DMSO) to a 20.8
mM stock solution was carried out at room temperature (23− 25 ◦C). For staining, slices
were transferred to a 60 x 15mm petri dish and kept for 15 min in carbogenated phys-
iological saline containing Di-4-ANEPPS (7.5 g/ml; <0.1% DMSO; Refojo et al., 2011;
von Wolff et al., 2011). The physiological saline (pH 7.4) consisted of (in mM): 125 NaCl,
2.5 KCl, 25 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2, and 25 glucose. Afterwards, slices
were transferred back to the maintenance chamber and stored at room temperature for a
minimum of 30 min in Di-4-ANEPPS-free, but bicuculline methiodide (BIM)-containing
(0.6 µM) carbogenated physiological saline (only exception, Figure 4.23).
3.3 Brain slice experiments
VSDI and field exitatory postsynaptic potential (fEPSP) recordings were conducted at
room temperature on a vibration-cushioned table (TMC; Peabody; USA), equipped with
a Faraday cage (TMC; Peabody; USA) to minimize extraneous electrical noise. In the sub-
merged recording chamber, slices were fixed with a custom made platinum frame/nylon
string harp ("grid") and continuously superfused with BIM (0.6 µM), containing carbo-
genated physiological saline (4-5 ml/min flow rate). The circulation was established by
using a combination of a gravity system (for influx) and a peristaltic pump (Ismatec; Glat-
tburg; Germany; for outflow). Thus, vibrations at the surface of the superfusion medium
were avoided. These settings minimize motion artifacts during recordings which is in-
dispensable for VSDI experiments. Figure (3.1A) depicts one representative slice that was
cut at a distance between 2.3 and 3.0 mm (± 0.1 mm) from the ventral base of the brain.
Pilot experiments revealed that hippocampal trisynaptic circuit (HTC)-waves can be most
reliably evoked in these particular slices. According to the "ventral/dorsal HIP hypoth-
esis" (Maggio and Segal, 2007; Fanselow and Dong, 2010), experiments were conducted
in the dorsal HIP or in the intermediate zone. EC/DG-input was evoked by electrical
stimulation of the PP, which also contains fibers that directly innervate the most distal
apical dendrites of CA3 pyramidal neurons (Steward, 1976; Andersen et al., 2006). After
fixation of the slice, but before placing stimulation or recording electrodes, these fibers
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were cut at the tip of the suprapyramidal blade, the point where they exit the DG (Figure
3.1A). Temporoammonic projections (Andersen et al., 2006) were likewise functionally
inactivated by a cut, ranging from the hippocampal fissure to the cortical surface (Figure
3.1A). The deafferentations were accomplished by means of a tapered scalpel blade and
a custom-made "microknife" (approximately 100 µm blade length; Figure 3.1B).
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Fig. 3.1. Deafferentiations performed in hippocampal brain slices. (A) Illustration of deafferentiations
performed with a scalpel blade and the microknife in hippocampal brain slices. (B) Custom made microknife
used for cutting direct cortical inputs to areas CA3 and CA1 (A, modified from Stepan et al., 2012).
The scalpel blade was used for a first, rough cut on the tissue block directly following
the slicing procedure. The "microknife" was made by breaking out small pieces from a
standard razor blade. Under a microscope, the quality of the "microknife" was checked.
When the respective "microknife" quarried out, it was glued into a shortened 1.5 mm
borosilicate glass pipette (Harvard Apparatus; Edenbridge; UK). This construction was
then coupled to a microelectrode holder. Thereby, the "microknife" could be utilized to
precisely round out the "pre-cut" generated by the scalpel blade (Figure 3.1A,B).
3.4 Voltage-sensitive dye imaging (VSDI)
VSDI and data analysis were performed using the MiCAM02 hard- and software pack-
age (BrainVision; SciMedia Ltd.; Costa Mesa; USA). The tandem-lens fluorescence mi-
croscope was equipped with the MiCAM02-HR camera (charged coupled device (CCD)
camera) and a 2x and 1x lens at the objective and condensing side, respectively (Figure
3.2).
By means of a halogen light source (MHAB; 150W; Moritex Corp.; Tokyo; Japan), an
excitation filter (530 nm pass) and a dichroic mirror (520 ∼ 560 nm reflect (>90%), 600
nm (>85%) pass), light with a specific wavelength was reflected towards the objective
lens to illuminate the brain slice, stained with Di-4-ANEPPS (Tominaga et al., 2000). It
is well known that fluorophores (e.g., Di-4-ANEPPS) absorb light energy (photons), a
process that sometimes can move an electron into a different orbital, the so-called exited
state (within fs). Fluorescence emission is one way how a fluorophore returns to its low-
energy ground state. Due to energy loss in the excited state, the emitted light has a longer
wavelenght. The difference between the exciting and emitted wavelengths is known as
Stokes shift (Lichtman and Conchello, 2005). Accordingly, emitted photons (fluorescence)
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Fig. 3.2. Voltage-sensitive dye imaging. (A) Components used for imaging of neuronal activities, by
means of fluorescence emitted from voltage-sensitive dyes, recorded with a CCD camera. (B) Electrochromic
voltage-sensitive dyes, are believed to sense voltage via the Stark effect. Upon depolarization, the emission
spectrum of Di-4-ANEPPS shifts to shorter wavelengths (eletrochromatic effect; dotted line), with a con-
comitant decrease of the area under the curve (4F) of integrated wavelengths > 590nm. (B, modified from
Canepari and Zecevic, 2010, p.16). Abbreviations: 4F, change in fluorescence; Vm, membrane voltage; VSD,
voltage-sensitive dye.
were collected and projected onto the CCD sensor through an emission filter (> 590nm;
Figure 3.2; Tominaga et al., 2000).
The fast styryl dye used here, interacts directly with the electric field and the charge
distribution over the molecule depends on the membrane voltage which additionally
displays a linear relationship to the amount of photons emitted (Fluhler et al., 1985;
Loew, 1992; Miller et al., 2012). One hypothesis is that excitation of the dye with a si-
multaneously occurring change of the membrane potential alters the excited state molec-
ular dipole (electrochromic effect, within ns) shifting its emission spectrum to longer
(excited state molecular dipole is stabilized = hyperpolarization) or shorter (the charge
shift inverted state is destabilized = depolarization) wavelengths (Stark effect;4F). These
bathochromic or hypsochromic shifts are accompanied by a concomitant decrease or in-
crease of the area under the curve. This allows to differentiate between excited and/or
unexcited tissue and to calculate the fractional change of fluorescence (%4F/F) for each
pixel, thus reflecting a direct measurement of neuronal activity (Figure 3.2; Canepari and
Zecevic, 2010; Loew, 1992; Miller et al., 2012; Tominaga et al., 2000). Because the elec-
tric field and the energy levels of the fluorophore directly interact, the kinetics of voltage
sensing occur on a timescale commensurate with absorption and emission, resulting in
ultrafast spectral emission shifts (fs to ps) many orders of magnitude faster than required
to resolve action potentials in neurons (Miller et al., 2012). Typical values for changes of
4F in neuronal tissue stained with Di-4-ANEPPS range around 10% per 100 mV. Unless
noted otherwise, standard settings of the MiCAM02-HR camera system were as follows:
88 x 60 pixels frame size, 36.4 x 40.0 µm pixel size, and 2.2 ms sampling time.
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3.5 Processing and quantification of VSDI data
From recorded VSDI signals, % 4F/F for wavelengths > 590 nm was calculated. For
all quantifications, % 4F/F values were spatially and temporally smoothed, using a 3
x 3 x 3 average filter. VSDI signals presented in images were smoothed with a 5 x 5 x
3 average filter. To attenuate slow signal components produced from bleaching of the
voltage-sensitive dye (Carlson and Coulter, 2008) and a slight summation of 5 and 20
Hz neuronal responses, a weak high-pass filter of the MiCAM02 software was applied
(τ= 220 ms) to the imaging data afterwards. Pixelation of images was reduced by the
interpolation function of the MiCAM02 software.
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Fig. 3.3. Quantification of the fast, depolarization-
mediated VSDI signal. To quantify FDSs, the value
(% 4F/F) before stimulus onset (107.8 ms) was sub-
tracted from the value at FDS peak amplitude (110
ms).
For analysis of neuronal population ac-
tivity in hippocampal subregions, three
standardized region of interest (ROI) were
manually set according to anatomical
landmarks. The circular CA3-ROI (r = 4
pixels) was placed into the CA3 region
close to the DG, but not overlapping with
it. The circular CA1-ROI (r = 4 pixels)
was positioned into the CA1 subfield at
a distance of ∼ 200 µm from the visu-
ally identified distal end of the stratum lu-
cidum. The CA3-ROI spanned the stratum
oriens, stratum pyramidale, and stratum
lucidum/radiatum (Figure 4.2A).
This was also the case for the CA1-ROI,
with the exception of the LTP experiments,
where it only covered the stratum radiatum (r = 2 pixels; Figure 4.18A). The polygon
DG-ROI (composed of ∼ 450 pixels) enclosed the outer two layers of the DG (without
the hilus) and was created by the polygon-drawing function of the MiCAM02 software
(Figure 4.18A). The average of smoothed %4F/F values within a particular ROI served
as final measure of neuronal population activity. For further analysis in BrainVision, the
peak amplitude of the fast depolarization-mediated signal (FDS) was corrected (Figure
3.3), to avoid that background fluorescence (noise) biased FDS values during LTP- and
pharmacological experiments. From all data presented in absolute values (only for illus-
tration of results) the peak amplitude was determined in Excel (Version 2003; Microsoft;
Redmond; USA) without applying the correction procedure.
3.5.1 HTC-wave assay adjustments for group comparisons
The voltage range (15-35 V), to generate comparable CA1-FDSs (0.1 to 0.3 %4F/F) dur-
ing baseline recordings in pharmacological experiments was quite limited (see Results,
4.1.4). However, to minimize variance in the input signal, the HTC-wave assay was
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further adapted for cross-slice and animal comparisons (Figures 4.1, 4.27A,B). This nor-
malization is supposed to be prerequisite for evaluating functional meanings of changes
caused by chronic stress. Instead of fixed voltage intensities, the levels of FDSs within a
specific DG-ROI were used. This polygon dentate gyrus supra (DGS)-ROI (composed of
∼ 150 pixels) covered the outer two-third of the DG suprapyramidal ML (corresponding
to the synaptic input field of the PP; Figure 4.27B; Andersen et al., 2006). Single-pulse
EC/DG-input served to adjust activity levels within the DGS-ROI. Pilot experiments re-
vealed that DGS-FDS activity levels of 0.35/0.45/0.55 % 4F/F (default DGS-FDS) cov-
ered nearly the complete dynamic range of input signals, which were capable of inducing
HTC-waves without producing epileptic-like activity (Figure 4.28). Furthermore, increas-
ing the FDS within this particular ROI was associated with a linear increase in subsequent
CA3-, and CA1-FDSs (Figure 4.28). On each adjusted intensity level, 15 stimuli at 5 Hz
were applied to the PP. The first FDS in the DGS-ROI and the mean of the last three FDSs
in areas CA3 and CA1 were used as final measure of neuronal activity (Figure 4.28).
Recordings were obtained from 2 to 3 slices per animal and subsequent statistical analy-
sis was performed on individual animal basis.
3.6 Field potential recordings
Field potentials in the CA3 stratum lucidum and CA1 stratum radiatum were recorded
using borosilicate glass pipettes (Harvard Apparatus; Edenbridge; Kent; UK) (1 MΩ
open-tip resistance) that were filled with BIM (0.6 µM) containing physiological saline.
Recorded data was low-pass filtered at 1 kHz and digitized at 5 kHz. Recorded signals
were stored (Macintosh 7100; Apple Inc.; Cupertino; USA) and fEPSPs and population
spikes were analyzed using the Pulse Software and macros written in Igor Pro (Version
6.12a; WaveMetrics Inc.; Lake Oswego; USA).
3.7 Electrical stimulation techniques
In all experiments, neuronal activity was evoked by square pulse electrical stimuli (200
µs pulse width), delivered through custom-made monopolar tungsten electrodes (Teflon-
insulated to the tip of 50 µm diameter). These electrodes enabled a very precise placement
into the neuronal tissue at the stimulation site and did not interfere with the imaging pro-
cess (e.g., by producing irritating shadows as observed with other electrodes). A highly
localized electrical stimulation was achieved by placing the indifferent electrode far away
from the slice in the recording chamber. During recordings which required two stimu-
lation electrodes (CA1 LTP experiments), the currently unused electrode was uncoupled
from the stimulation device in order to avert an indirect application of voltage to the
inactive electrode. The electrode used for evocation of EC/DG-input was placed un-
der a binocular on the visually identified PP at distance of 40 µm (± 10 µm) away from
its entry zone into the DG, to avoid direct stimulation of neurons and their dendrites
within the ML (Figure 4.18A). Baseline recordings in stratum radiatum were done to
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monitor putative alterations in the strength of neurotransmission at SC to CA1 synapses
in LTP experiments. Using stimulation of the SC-commissural pathway near the CA3
averted boundary of the CA1-ROI, a large fraction of the CA3 to CA1 synapses was an-
tidromically (Bliss and Collingridge, 1993) activated under both conditions, during base-
line recordings and after LTP induction. This approach recruited commissural fibers just
as SCs which were cut somewhere in the CA3 or CA1 region during preparation of brain
slices. Low stimulation intensities evoke neuronal activity within the CA1-ROI that may
be overlaid with signals resulting from activation of such "irrelevant" fibers. To minimize
the probability of interference, a stimulation intensity which produced a strong fEPSP
and, thus, a concomitant population spike was used (Figure 4.18; Stepan et al., 2012).
For analysis of VSDI experiments neither the peak amplitude nor the slope of CA1-FDS
could be used as proper measure of changes in the strength of neurotransmission at CA3
to CA1 synapses. This is due to the fact that in contrast to field potential recordings,
VSDI displays action potentials and EPSPs always as signals exhibiting the same deflec-
tion course (Carlson and Coulter, 2008). To overcome this problem and thereby render
LTP experiments via VSDI possible, the amplitude of a later CA1-FDS component was
used as such a measure (frame 13, 28.6 ms after the stimulation pulse (FDSF13); Stepan
et al., 2012). By means of simultaneous VSDI and field potential recordings, Stepan et
al. (2012) showed that the FDSF13 value reflects the amplitude of the glutamatergic fEPSP
during its decaying phase. Using the FDSF13 amplitude with a value in the range between
60-80 % of the CA1-FDS peak amplitude revealed that increasing the stimulation inten-
sity or adding the AMPA receptor potentiator cyclothiazide (100 µM; Eder et al., 2003;
Stepan et al., 2012) further increased the FDSF13 signal in field potential and VSDI record-
ings (Figure 4.18). Moreover, the induction of populations spikes with high stimulation
intensities showed that at this particular point of time, fEPSPs do not mingle with action
potentials fired by CA1 pyramidal neurons anymore (Stepan et al., 2012). Further evi-
dence supporting the use of the FDSF13 amplitude in the LTP experiments comes again
from VSDI combined with field potential recordings. 5 Hz EC/DG-input for 6 s, which
evoked CA1 LTP as measured with VSDI, caused a long-lasting increase in the slope and
the amplitude of fEPSPs, 28.6 ms after the stimulation pulse (Figure 4.18C).
3.8 Fluorescein-guided administration of drugs to brain slices
For local application of DCG-IV (see Appendix 8.1) and D-APV to hippocampal sub-
fields CA3 and CA1, a non-invasive pressure application was used. All following steps
were visually guided under a binocular. After baseline recordings, the camera unit was
removed and a borosilicate glass pipette (0.2-0.3 MΩ open-tip resistance) mounted on
a micromanipulator was positioned in the neuronal tissue beyond the HIP. The glass
pipette was filled with physiological saline containing BIM (0.6 µM), fluorescein (FLUO)
(10 µM) and the drug to be applied. The filling was done just before pressure application
to avoid blinding of the tip. Subsequently, the tip of the pipette was slightly moved into
the brain tissue and pulled out of the slice again with a defined number of steps using
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the micromanipulator. This procedure ensured an appropriate and comparable position
of the tip of the pipette in relation to the surface of the slice for all experiments. To avoid
damage of neuronal tissue by the pressure ejected fluid, the horizontal end-position was
set somewhat above the region of interest. FLUO, whose fluophoric characteristics were
triggered by means of light emitted from a UV diode (Conrad; Hirschau; Germany; 405
nm), served to visually guide the spread of the pressure ejected fluid (Figure 4.14A). Pilot
experiments revealed that a spatially restricted drug application on the region of interest
could be achieved by thoroughly setting the following parameters (Figure 4.14A):
• The resistance of the glass pipette (size of the aperture)
• Capitalization of the ejected fluid on the stream of the superfusion medium through
the recording chamber
• Appropriate adjustment of the strength of pressure applied to the electrode
• The distance of the tip of the pipette in relation to the slice surface (see above)
• The specific orientation of the slice within the recording chamber to exclusively
cover the region of interest.
In the FLUO-guided experiments, somewhat higher concentrations of drugs were used
than typically bath-applied to reach the maximum pharmacological effect. This was done
since drugs (DCG-IV and D-APV) had to rapidly penetrate the neuronal tissue by diffu-
sion and, second, the application duration was restricted to a few seconds. Pilot ex-
periments revealed that excessive application of FLUO increases the VSDI signal above
baseline. Therefore, both, the period of application and the concentration of FLUO were
kept as low as possible. A FLUO concentration of 10 µM and application times of ap-
prox. 60" were suited to avoid effects on the VSDI signal (Figure 4.22). Nevertheless,
control applications of FLUO alone were carried out in all sets of experiments. The spa-
tial restriction of the FLUO-guided drug administration on the region of interest was
verified by bath application of DCG-IV at a concentration of 1 µM (Kew et al., 2002;
Nicoll and Schmitz, 2005). DCG-IV decreased evoked neuronal activity in the DG, con-
sistent with its inhibitory effect on glutamatergic neurotransmission at PP synapses (Fig-
ure 4.14B; Kew et al., 2002). If DCG-IV was specifically applied to area CA3, this effect
was not observed (Figure 4.15). Next, a set of control experiments was done to determine
which concentration of pressure applied D-APV leads to a complete block of NMDA re-
ceptors. Different pressure-applied concentrations of D-APV were compared to bath ap-
plication of D-APV at the standard concentration of 50 µM (Avrabos et al., 2013). These
control experiments revealed that D-APV, pressure applied for 1 min at a concentration
of 200 µM, reduced the FDSF13 amplitude of CA1-FDSs to nearly the same extent as bath
applied D-APV at 50 µM (Figure 4.22).
3.9 Chemicals
See Table (8.1).
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All salts for the physiological saline solutions were purchased from Sigma-Aldrich. For
chemicals not solved in artificial cerebrospinal fluid, the corresponding amount of sol-
vent was added during baseline recordings. Corticosterone was dissolved in ethanol,
which was present at a concentration of 0.009% during experiments. Diazepam and
Haloperidol were dissolved in DMSO, which was present at a maximum concentration
of ≤ 0.001% and ≤ 0.02%, respectively.
3.10 Statistics
For statistical comparisons between groups, the data were checked for normality distri-
bution and equal variance. If the criteria where met, statistical significance was assessed
by paired t-est, unpaired t-tests or analysis of variance (ANOVA) when appropriate;
when the criteria were not met, a Mann-Whitney U-test or a Kruskal-Wallis ANOVA on
ranks were used. Analysis of stimulation strength intensities was performed using one-
way ANOVA for repeated measures. ANOVAs were followed by the appropriate post-hoc
test (see figure legends). All tests were run in SigmaStat (Systat Software; Chicago; USA)
and differences were considered significant if p < 0.05. Data are given as mean ± s.e.m.
Chapter 4
Results
The results are organized in the following way: The first section examines the character-
istics of polysynaptic activity flow through the trisynaptic circuit of the HIP, sections two
and three assess how this phenomenon is influenced by chronic stress and antidepressant
drugs.
4.1 Polysynaptic activity flow in the hippocampus
Previous work shows that VSDI is suited to monitor disynaptic activity propagation
within the HIP by direct stimulation of DG granule cells (von Wolff et al., 2011). Here,
non-synaptic activation of hippocampal neurons was avoided by electrical stimulation of
the PP, which constitutes the main axon bundle conveying information from the EC to
the HIP (Figure 4.1, 4.2A).
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Fig. 4.1. Experimental setup for recordings of polysynaptic activity flow in the HIP. Arrangement used for
investigations shown in Figures (4.3 - 4.11). Abbreviations: FPR, field potential recording; MF, mossy fiber;
SC, Schaffer collateral; Stim, extracellular electrical stimulation; TA, temporoammonic pathway (adapted
from Stepan et al., 2012).
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This EC/DG-input opens the possibility to investigate manifold aspects of trisynaptic
activity flow through the HIP. DG granule cells give rise to the anatomically most promi-
nent non-commissural/associational innervation of CA3 pyramidal cells. This may also
render EC/DG-input the major trigger for physiological phenomenons like CA1 LTP.
Consequently, PP fibers that directly innervate areas CA3 and CA1 (temporoammonic
pathway) were micro-dissected via surgical cuts in all following experiments to ensure
that hippocampal activity solely arises from EC/DG-input (Figures 4.1, 3.1A). As VSDI
measure of neuronal activity, "regions of interest" (ROIs)-extracted fast, depolarization-
mediated imaging signals (FDSs) were used (Figures 4.1, 4.2A, 4.3; Airan et al., 2007;
Refojo et al., 2011; Tominaga et al., 2000; von Wolff et al., 2011).
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Fig. 4.2. Anatomical position of ROIs and experimental protocol. (A) Illustration of the position of ROIs
in relation to important landmarks in the HIP. (B) Experimental protocol used for investigations shown in
Figures (4.3 - 4.11). Abbreviations: SL, stratum lucidum; SR, stratum radiatum (A,B, adapted from Stepan et
al., 2012).
After staining of brain slices Di-4-ANEPPS, every neuronal membrane contributes to the
resulting fluorescent signal, but the exact contribution of each part of the neuron (den-
drites, soma, axon) and neuronal signal components (action potentials, EPSPs) has not
been conclusively answered until now (Chemla and Chavane, 2010; Carlson and Coul-
ter, 2008). Thus, it is rational to state that stimulus-evoked FDSs in hippocampal slice
preparations represent a multi-component signal, reflecting neuronal action potentials as
well EPSPs of all neurons monitored in a given ROI. Consequently, FDSs are abolished
or at least strongly diminished by voltage-gated Na+ channel blockers or ionotropic glu-
tamate receptor antagonists and lowered extracellular Ca2+ concentrations, respectively
(Airan et al., 2007; Carlson and Coulter, 2008; Chemla and Chavane, 2010; Tominaga et
al., 2000).
4.1.1 Evoked theta-rhythmical activity in the perforant pathway
It is well established that the hippocampal theta rhythm (3-8 Hz) represents the "on-line"
state of the HIP and the induction of specific memories is associated with theta activity in
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the entorhinal-hippocampal system (Axmacher et al., 2006; Berry and Thompson, 1978;
Buzsàki, 2002; Rutishauser et al., 2010; Winson, 1978). Using brain slices, optimized for
preservation of intrahippocampal connections, it was first tested whether repeated theta-
rhythmical (5 Hz) EC/DG-input triggers hippocampal network dynamics which, except
for their rate of occurrence, differ from those elicited by non-theta (0.2 Hz) EC/DG-input
(Figure 4.2B).
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Fig. 4.3. Hippocampal activities in response to 0.2 and 5 HZ EC/DG-input. Open triangles symbolize an
interruption of VSDI for 4.34 s. Stimulus artifacts in FPR traces were truncated for clarity (adapted from
Stepan et al., 2012).
Repetitive (0.2 Hz) EC/DG-input triggered prominent neuronal activity in the DG, but
only slight neuronal activity in the CA3 region, and no detectable neuronal activity in
area CA1 (Figures 4.3, 4.4). These experiments also revealed that unlike direct stimulation
of DG granule cells (von Wolff et al., 2011), single pulses applied to the PP are not capable
of triggering trisynaptic activity flow through the HIP (Figures 4.3, 4.4).
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Fig. 4.4. Quantification of neuronal activities in hippocampal subregions. Neuronal activity was moni-
tored using voltage-sensitive dyes and FPRs (N = 9 slices/5 mice) (adapted from Stepan et al., 2012).
In contrast to non-theta low frequency pulses, 5 Hz EC/DG-input reliably generated
waves of neuronal activity which propagated through the entire trisynaptic circuit of
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2012).
the HIP (HTC-waves; Figures 4.3, 4.4, 4.5, 4.6A). This polysynaptic activity flow started
to appear in an initially progressive manner, with complete percolations from approxi-
mately the third stimulus on. This corresponds to 600 ms after initiation of EC/DG-input.
HTC-waves precisely followed the input rhythm. FDSs in the DG occurred ∼ 4 ms after
PP stimulation and in CA3 and CA1 with a delay of ∼ 12.5 ms and ∼ 20 ms, respectively
(Figures 4.3, 4.4, 4.6A).
Further analysis of FDSs and fEPSPs revealed that neuronal activity in the DG slightly
decreased during 5 Hz EC/DG-input (Figures 4.3, 4.4) .This reduction presumably re-
sults from a known habituation process that involves GABAergic neurotransmission and
the preferential recruiting of inhibitory interneurons in the DG after focal PP stimula-
tion (Ewell and Jones, 2010; Teyler and Alger, 1976). A pharmacological blockade of
ionotropic glutamate receptors completely abolished HTC-waves (Figure 4.6B).
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Fig. 4.6. Characteristics of neuronal activities in response to 5 Hz EC/DG-input. (A) The latency to onset
after electrical stimulation of PP axons in hippocampal subfields from experiments depicted and quantified
in Figures 4.3 - 4.5 (B) Bath application of the AMPA/kainate receptor blocker NBQX (5µM) and the NMDA
receptor antagonist D-APV (50 µM) to slices, fully inhibited neuronal activity in the HIP (A, N = 9 slices/5
mice) (A,B, adapted from Stepan et al., 2012).
4.1.1.1 HTC-waves involve high-frequency firing of CA3 pyramidal neurons
A closer examination of the CA3 (SL) field potential recordings suggests that HTC-waves
involve high-frequency firing of CA3 pyramidal neurons. Here, multiple population
spikes, which represent the synchronous firing of several neurons, accompanied the typ-
ically fast rising MF fEPSPs (Figure 4.7; Nicoll and Schmitz, 2005; Toth et al., 2000). Both,
the rate and the number of these population spikes (173 ± 19 Hz; Figure 4.7) correspond
to the characteristics of physiological burst firing of CA3 pyramidal neurons (Andersen
et al., 2006, p.157). This resulted in a prominent SC fEPSP as reflected by pop-spikes
that were also interlaced in this signal (Figure 4.7). This indicates that HTC-waves likely
elicit action potentials in CA1 pyramidal neurons, which provide a major source of exci-
tatory output of the HIP targeting numerous brain regions, including the EC (Figure 4.7;
Andersen et al., 2006).
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(adapted from Stepan et al., 2012).
4.1.1.2 Non-theta frequency stimulations are much less effective in inducing HTC-
waves
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Fig. 4.8. Induction of HTC-waves by non-theta frequency EC/DG-input. (A,B) Quantification of CA1
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EC/DG-input (A,B; 0.2/5 Hz: N = 9 slices/5 mice, 1 Hz: N = 9 slices/6 mice, 20 Hz: N = 11 slices/6 mice)
(A,B, adapted from Stepan et al., 2012).
Several lines of evidence suggest that DG granule cell activity may be subject to a tightly
regulated, frequency-dependent inhibitory control (Andersen et al., 1966; Mott and Lewis,
1992). To potentially corroborate this notion, it was determined whether and how effec-
tively non-theta (1 and 20 Hz) EC/DG-input generates activity percolations through the
HTC. Neuronal activity was triggered reliably in all three subfields, but activity propaga-
tions were considerably less strongly pronounced than those produced by 5 Hz EC/DG-
input (Figure 4.8A). Furthermore, these experiments revealed that the aforementioned
decline of DG activity was more distinct during 20 Hz EC/DG-input. The opposite sce-
nario was observed for 0.2 and 1 Hz EC/DG-input with a markedly lower decrease of
DG activity levels (Figure 4.8B).
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4.1.1.3 Rationale for the use of bicuculline methiodide
Pilot experiments revealed that a minimum experimental variability in HTC dynamics
can be achieved when brain slice stimulations were carried out in the presence of bicu-
culline methiodide (BIM). If not stated otherwise, 0.6 µM (BIM) was added to all salines
after staining the brain slices with Di-4-ANEPPS. The improvement for initiation of HTC-
waves critically depends on concentration of the GABAA receptor antagonist, since ex-
cessive increases of BIM can cause hyperexcitability of the hippocampal network (Figure
4.9; Swann et al., 2007).
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F19
41.8 ms
20 µMBIM
F19
41.8 ms
0.6 µM
Stim
0.60.3 ΔF/F (%)
Fig. 4.9. High concentration of BIM causes epileptiform activity in the HIP. Single-pulse activation of
EC/DG-input causes moderate, spatially restricted neuronal activity in the HIP in BIM (0.6 µM)-treated
slices. A subsequent increase to 20 µM led to enormous epileptiform activity in all hippocampal subfields
(adapted from Stepan et al., 2012).
A weakly blocking dose is justified for the following reasons: First, specific excitatory in-
terneurons in the HIP (e.g., mossy cells) heavily cross the transverse axis. Thus, it is likely
that the intact brain contains more excitatory circuitry than slices (Jackson and Scharf-
man, 1996). Second, the relatively long axons of principal neurons are cut to a greater ex-
tent during preparation of slices, than the short projections of hippocampal GABAergic
interneurons (Andersen et al., 2006). These considerations point to an unproportional
enhancement of inhibition in large-scale hippocampal circuits in vitro (e.g., (Iijima et al.,
1996). And third, recent evidence suggests that the voltage-sensitive dye used here (Di-
4-ANEPPS) slightly potentiates GABAA receptor function (Mennerick et al., 2010). BIM
at the considerably low concentration of a 0.6 µM almost never led to epileptiform ac-
tivity in the hippocampal subfields under investigation (Figure 4.9). Nevertheless, every
experiment was analyzed with respect to such activity and, in the rare cases in which
epileptiform like activity was observed (<1% of experiments; Figure 4.9), slices were dis-
carded from subsequent analysis. Although less strongly pronounced, EC/DG-input in
the absence of BIM also reliably triggered HTC-waves (Figure 4.10B).
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4.1.1.4 Level of HTC-waves depends on stimulation intensity
Because the VSDI signals can be very small, relatively high stimulation intensities were
used to evoke EC/DG-inputs. This ensures both, a proper signal-to-noise ratio in combi-
nation with utilization of BIM, a minimum experimental variability in HTC dynamics.
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In detail, the induction of HTC-waves was preceded by single-pulse EC/DG-inputs to
generate an input/output curve for every slice. Accordingly, the intensity of voltage
during PP stimulations was adjusted in a manner to produce DG-FDSs with peak am-
plitudes of maximally 80% of the highest attainable value. The resultant FDSs ranged
at the end of the linear upturn of the previously obtained input/output curve (Figure
4.11A). Hence, EC/DG-input may caused spiking of a substantial population of DG
granule cells. Under in vivo conditions, however, recent experimental evidence suggests
sparse firing of DG granule cells (Pernía-Andrade and Jonas, 2014; Henze et al., 2002;
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Jung and McNaughton, 1993; Leutgeb et al., 2007). Therefore, it was examined whether
polysynaptic activity flow within the HIP also occurs if only a small number of PP axons
became activated. For this purpose, the stimulation intensity was decreased by signifi-
cant steps (10 %) in a gradual manner down to 40 % of the highest achievable activity
level in the DG. Providing substantial evidence for the sparse coding theory of DG gran-
ule cells, HTC-waves were also triggered with considerably lower activity states of the
DG. Additionally, the resultant HTC-waves were characterized by a continuously decline
in their strength, rather than by an abrupt drop off (Figure 4.11B).
4.1.2 HTC-waves depend on mossy fiber to CA3 synaptic transmission
The delayed and initially progressive appearance of HTC-waves (Figures 4.3, 4.4) indi-
cates that the 5 Hz EC/DG-input somehow unlocked a frequency-dependent "gate" in
the HTC for passages of neuronal activity. This comprises a two-dimensional process
(unlocking/period) which may account for the amount of information flow. First, pro-
nounced frequency facilitation of MF to CA3 synaptic transmission (Nicoll and Schmitz,
2005; Toth et al., 2000) may serve as the pivotal unlocking mechanism. A supporting
factor for this scenario is the observation that frequency facilitation heavily took place
during 5 Hz EC/DG-input, while neuronal activity in the DG decreased (Figures 4.3,
4.4).
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Fig. 4.12. Experimental setup used for spatially restricted administration of drugs to hippocampal sub-
fields. Arrangement used for investigations shown in Figures (4.13 - 4.15) (adapted from Stepan et al., 2012).
Providing a direct proof that CA3 MF synaptic transmission is paramount in trigger-
ing HTC-waves, CA3-FDSs disappeared if glutamate release at CA3 MF terminals was
selectively blocked by applying the mGluR2 agonist DCG-IV (Nicoll and Schmitz, 2005;
Toth et al., 2000) specifically to area CA3 (Figures 4.12, 4.13A, 4.15). Frequency facilitation
at MF synapses is a short-lasting form of synaptic plasticity (Nicoll and Schmitz, 2005).
This characteristic may determine the timescale for opening of the "gate" and to exclude
runaway excitation of the HTC. It is thus tempting to speculate that HTC-waves dissi-
pate within a couple of seconds if 5 Hz EC/DG-input is followed by low-frequency (0.05
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Hz) EC/DG-input (Toth et al., 2000). This was the case and reoccurring 5 Hz EC/DG-
input again generated HTC-waves which displayed a delayed and initially progressive
emergence (Figures 4.13B).
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42 CHAPTER 4. RESULTS
B
Single-pulse stimulation
???
P e
a k
 a
m
p l
i t u
d e
 o
f
D
G
- F
D
S  
( n
o r
m
a l
i z
e d
)
0.8
0.6
0.4
1.0
0 6 12 18
Time (min)
24 30 36 42
1.6
1.4
1.2
DCG-IV
Stim
Stream of superfusion
medium (saline)
Colored saline
containing
DCG-IV
P
A
CA3
Stim1
Stim2P
CA1
Colored saline
containing
APV
Fig. 4.14. Spatially restricted drug administration. (A) Illustration of the locally restricted FLUO-guided
administration of DGC-IV and D-APV to areas CA3 and CA1. For a better visualization of the spread of the
pressure-ejected saline, Ponceau S was added instead of FLUO to the pipette solution. (B) Bath application
of 1µM DCG-IV to brain slices markedly reduced neuronal activity in the DG (B, N = 6 slices/3mice). (B)
***p < 0.001 (paired t-test) (A,B, adapted from Stepan et al., 2012).
0.35
0.25
Δ F
/ F
( %
)
Minute 5 (10th FDS)
F20
44 ms
Fluo
F20
44 ms
Minute 10 (10th FDS)
Fluo+DCG-IV
Selective pharmacological
treatment of area CA3
Time (min)
P e
a k
 a
m
p l
i t u
d e
 o
f  1
0 t
h  
F D
S
( n
o r
m
a l
i z
e d
)
0.8
1.0
1.2
1.4
1.6
0.6
0.4
0.2
0
DG-ROI
CA3-ROI
CA1-ROI
0 10 20 30 40
Fluo Fluo+DCG-IV
???
??
Fig. 4.15. Selective pharmacological treatment of area CA3. A selective shutdown of MF synaptic transmis-
sion by a FLUO (10 µM)-guided administration of the mGluR2 agonist DCG-IV (30 µM; 1 min) specifically
to area CA3 abolished HTC-waves without affecting DG activity (N = 8 slices/6 mice). ??p < 0.01 (paired
t-test); ???p < 0.001 (paired t-test); (adapted from Stepan et al., 2012).
4.1. POLYSYNAPTIC ACTIVITY FLOW IN THE HIPPOCAMPUS 43
4.1.3 Polysynaptic induction of CA1 LTP
Theta-burst stimulation of CA3 to CA1 projections is known to effectively induce CA1
LTP (Bliss and Collingridge, 1993), a cellular model of learning and memory in mam-
mals. Here, 5 Hz EC/DG-input triggered high-frequency discharges of CA3 pyrami-
dal neurons (Figure 4.7). This opens up the possibility that HTC-waves yield a kind of
"theta-burst" activation of CA3 to CA1 synapses. Consequently, it was tested whether 5
Hz EC/DG-input can elicit CA1 LTP. To enable the imaging of the putative formation of
CA1 LTP, the VSDI assay was refined. Beside 5 Hz electrical stimulation of PP axons, a
second electrode was placed into the SC-commissural pathway to accurately gauge the
strength of neurotransmission at CA3 to CA1 synapses. The amplitude of the CA1 (SR)-
FDSs at imaging frame 13 (28.6 ms) after the stimulation pulse (FDSF13 amplitude) in
response to repeated, low frequency stimulations of the SC-commissural pathway (Bliss
and Collingridge, 1993; Figures 4.16 - 4.18) was used, to measure changes in the strength
of neurotransmission at CA3 to CA1 synapses (Figure 4.18; "Materials and Methods").
Analysis of field potential recordings performed in CA1 stratum radiatum and VSDI data
showed that 5 Hz EC/DG-input for 6 s was sufficient to evoke CA1 LTP (Figures 4.18,
4.19; "Materials and Methods"). This CA1 LTP was not saturated, because a second train
of HTC-waves further increased its magnitude (Figure 4.20). Another set of experiments
suggests the existence of an induction threshold for this neuroplastic phenomenon. This
became evident by the observation that 10 stimuli were not sufficient for polysynaptic
induction of CA1 LTP (Figure 4.21). Furthermore, the form of CA1 LTP obtained here
critically depends on the activation of NMDA receptors (Bliss and Collingridge, 1993) as
revealed by the administration of the NMDA receptor blocker D-APV specifically to area
CA1 (Figure 4.22). 5 Hz EC/DG-input for 6 s also elicited CA1 LTP in the absence of BIM
(Figure 4.23). In all LTP experiments, hippocampal activity resulting from EC/DG-input
was monitored by means of VSDI (Figure 4.18 - Figure 4.23).
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Fig. 4.16. Experimental arrangement used for LTP experiments. Arrangement used for investigations
shown in Figures ( 4.18 - 4.23). Abbreviation: CF, commissural fiber (adapted from Stepan et al., 2012).
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4.1.4 Pharmacological modulation of HTC-waves
HTC-waves might provide a valuable assay for studying drug effects on polysynaptic
activity flow through the classical input/output circuit of the HIP. Because the HIP plays
a fundamental role in cognitive processes, like memory formation (e.g., CA1 LTP; Whit-
lock et al., 2006), it seems reasonable to examine the impact of the cognitive enhancer
caffeine (Nehlig, 2010) on HTC-waves. As already suggested by the DCG-IV and LTP
experiments (Figures 4.15, 4.21), stimulation trains containing 10 stimuli (every 5 min),
were suited to conduct stable baseline recordings of HTC-waves without inducing long-
term synaptic changes (Figures 4.13, 4.24A). In these experiments, the FDS amplitude
of the tenth stimulus served as measure of neuronal excitability. After stable baseline
recordings over a period of 15 min, bath application of caffeine at a concentration found
in the cerebrospinal fluid of humans after intake of 1-2 cups of coffee (5 µM; Fredholm et
al., 1999), boosted HTC-waves (Figure 4.24A). Martín and Buño (2003) reported that caf-
feine mediates a presynaptic form of LTP at CA3 to CA1 synapses. To exclude that such
LTP interferes with the caffeine-induced enhancement of HTC-waves, wash-out exper-
iments were conducted. Contradicting the involvement of long-term synaptic changes,
CA1-FDSs reverted to baseline strength if caffeine was removed from the superfusion
medium (Figure 4.24B).
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Fig. 4.24. Caffeine and CORT modulate HTC-waves. (A,B) Caffeine rapidly boosted HTC-waves in a
reversible manner. (C) CORT (100nm) quickly amplified HTC-waves (A, N = 8 slices/4 mice; B, N = 4
slices/3mice; C N = 7 slices/4mice). (A,B,C) ?p < 0.05 (paired t-test); ??p < 0.01 (paired t-test); ???p <
0.001 (paired t-test) (A,B, adapted from Stepan et al., 2012).
Several neuromodulators are tightly linked to hippocampal physiology in health and
disease. Especially CORT- and CRH receptors are densely expressed in the mouse HIP.
Their activation has been implicated in HIP-dependent functions like memory forma-
tion and stress response, but experimental demonstrations how acute application af-
fects polysynaptic activity flow in the HIP are lacking to date (Maras and Baram, 2012;
McEwen, 1999). As observed previously for caffeine, CORT (100 nM) rapidly amplified
HTC-waves (Figure 4.24C). Although 10 pulses at 5 Hz applied to the PP were not suffi-
cient to induce CA1 LTP (Figure 4.21), it was attempted to further minimize the number
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Fig. 4.25. Refined HTC-wave protocol for pharmacological experiments. (A) Experimental protocol used
for investigations shown in (Figure 4.26). (B) Recordings in the absence of drug revealed a slight decrease
(significant in the DG and CA3) of FDSs in all hippocampal subregions. (B, N = 10 slices/5mice). (B) ?p <
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of stimuli. Therefore, pilot experiments were carried out, testing stable baseline record-
ings with a reduced number of pulses (4 to 7) at a shorter time interval (2min; Figure
4.25A). The number of stimuli was held constant within an experiment. As a final mea-
sure of DG, CA3, and CA1 activity levels, the mean of the last FDS out of three consec-
utive acquisitions was used and paired t-tests were employed to determine the distinct
concentration(s) with significant change of FDSs at minutes 0 to 18 vs. minutes 42 to
60. Electrical stimulation intensity was set (15-35 V) in order to obtain CA1-FDS ranging
within 0.1 to 0.3 %4F/F. Applying these settings, control experiments in the absence of
any drug revealed a slight decrease (significant in DG and CA3) of FDS amplitudes in all
hippocampal subregions (Figure 4.25B). To avoid under-/overestimation of drug effects
the corresponding percentage of decrease (DG, 4.4 ± 1 %; CA3, 4.4 ± 2 %; CA1, 3.5 ± 2
%), was subtracted in subsequent experiments. Additionally, this refined experimental
protocol facilitated baseline recordings. If not stated otherwise, the adapted protocol and
the correction factor were applied in all experiments, starting with bath application of
CRH. CRH (5 and 50 nM), subsequently probed by means of this refined protocol, also
rapidly amplified HTC-waves at considerably low concentrations (Figure 4.26A,B).
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Fig. 4.26. CRH modulates HTC-waves. (A,B) Bath application of CRH (5 nM/50 nM) rapidly amplified
HTC-waves (A, N = 7 slices/4mice; B, N = 6 slices/3 mice). (A,B) ?p < 0.05 (paired t-test); ??p < 0.01
(paired t-test).
4.2 HTC-waves in an animal model of chronic stress
Beside pharmacological investigations, the HTC-wave assay appears suited to uncover
alterations in hippocampal network dynamics in animal models of disease. A constant
EC/DG-input is an important prerequisite to reliably compare output patterns (activity
in areas CA3 and CA1) across slices. In order to meet this objective (see Material and
Methods, 3.5.1), single pulse EC/DG-input was used to obtain FDSs within a specific
DG-ROI (DGS-ROI) with fixed values ("default DGS-FDS", low intensity = 0.35, middle
intensity = 0.45, high intensity = 0.55 %4F/F). Subsequently, 15 pulses at 5 Hz were ap-
plied at each intensity level (separated by 3 min) to induce HTC-waves (Figure 4.27A,B).
Experiments in wild-type C57BL/6N mice revealed a substantial match between the de-
fault DGS-FDS and the 1st DGS-FDS of a subsequent 15 pulse train at 5 Hz at all three
intensity levels (Figure 4.28A). Most importantly, CA3- and CA1-FDS amplitudes were
found to increase linearly within the stimulus range and reliably across slices (Figure
4.28B).
It is well established that sustained exposure of rodents to elevated stress levels results
in severe hippocampal damage, accompanied by an impairment of HIP-dependent cog-
nitive abilities (Kim and Diamond, 2002; McEwen, 2007). How this disturbed brain
homeostasis affects polysynaptic signal propagation within the HIP is unknown to date
(Pavlides et al., 2002). To elucidate the impact of chronic stress on HTC-waves, the ef-
ficacy of evoked EC/DG-input was examined in acute brain slices from chronic social
defeat stress (CSDS) and control (CTRL) mice (see Material and Methods, 3.1.1). For this
purpose, animals were tested after two weeks of defeat in a random manner and blinded
to the experimentalist on six consecutive days.
According to the initial experiments, the 1st DGS-FDS was precisely set in CTRL and
CSDS mice and no differences in DGS activity levels were detected (Figures 4.28A, 4.29,
4.31). Furthermore, CA3- and CA1-FDSs also increased linearly in the stimulus range
(Figures 4.30A), indicating a reproducible EC/DG-input across slices. In striking contrast
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to DG-FDSs, CA3- and CA1-FDSs were markedly weaker in brain slices obtained from
CSDS mice (Figures 4.31, 4.32). The only exception are signals in area CA3 at the lowest
intensity level (Figure 4.32). It has previously been shown that DG function is modified
by chronic stress and stress associated adjustments (Ikrar et al., 2013; Karst and Joëls,
2003). Therefore, stimulation intensities that were capable of inducing the default activity
levels in the DGS-ROI were analyzed and found to be markedly decreased in CSDS mice
(Figure 4.30B), indicating enhanced DG activity in stressed mice.
All animals were tested during the third week of CSDS on six consecutive days. Previous
work indicates that mice exhibit a constant phenotype and stable patterns of molecu-
lar, cellular and morphological changes in the HIP after 2 weeks of defeat (Berton and
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Nestler, 2006; Sousa et al., 2000). Nevertheless, to exclude the possibility that further
changes in the hippocampal network became apparent over time, the effect of testing
day on activity levels within the HTC was examined. This analysis revealed no relation-
ship between day of data acquisition and neuronal activity levels in areas CA3 and CA1
(Figure 4.33).
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Fig. 4.31. Quantification of neuronal activities in hippocampal subregions. CA3- and CA1-FDSs are
markedly decreased in CSDS mice (CTRL: N = 6 mice; CSDS: N = 7 mice).
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4.3 Circuit-level mechanism of antidepressant drug action
4.3.1 Antidepressants enhance HTC-waves at low micromolar concentrations
Considering that chronic stress markedly impaired activity percolations through the HTC
(Figure 4.29), it was tested whether and how ADs, the first line treatment for SRPDs,
modulate hippocampal network activity. Using the HTC-wave assay for pharmacolog-
ical investigations (Figure 4.25A,B), the acute effect(s) of various ADs (the tricyclic ADs
amitryptyline and clomipramine, the selective serotonine reuptake inhibitors (SSRIs) flu-
oxetine, citalopram and fluvoxamine, the selective serotonine/norepinephrine reuptake
inhibitor (SSNRI) venlafaxine, the selective serotonin reuptake enhancer (SSRE) tianep-
tine and the monoamino-oxidase A and B inhibitor (MAOI) tranylcypromine were tested
in nearly 450 brain slices.
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Fig. 4.34. Fluoxetine enhance HTC-waves in a TrkB-dependent manner but independent from CSDS
(A) Bath applied fluoxetine (10 µM) strongly enhanced CA3- and CA1 FDSs. (B) This effect is abolished
in the presence of the TrkB ligand ANA-12, but preserved in CSDS mice (C) Illustration and outcome of
one representative experiment showing the effect of bath-applied fluoxetine (10 µM) on HTC-waves. (D)
Illustration and outcome of one representative experiment showing the effect of bath-applied fluoxetine (10
µM) and ANA-12 (10 µM) on HTC-waves. (A, N = 7 slices/4 mice; B, fluoxetine + ANA-12: N = 11 slices/4
mice; CSDS: N = 8 slices/4 mice). (A,B) ?p < 0.05 (paired t-test); ??p < 0.01 (paired t-test); ∗p < 0.05
(unpaired t-test); ∗∗p < 0.01 (unpaired t-test). Abbreviations: FLX, fluoxetine.
ADs are known to effectively elevate brain serotonin and/or norepinephrine levels (caused
by inhibition of the corresponding reuptake transporters or monoamine oxidases) at
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low nanomolar concentrations (Boldenwatson and Richelson, 1993; Tatsumi et al., 1997).
However, recent evidence suggests that they also modulate several other targets (e.g.,
neurotrophin receptors, ion channels) at high nanomolar/low micromolar concentra-
tions (Jang et al., 2009; Méndez et al., 2012; Rammes and Rupprecht, 2007). Therefore,
ADs at different concentrations (0.1, 0.5, 1, 5, 10, and except for tianeptine also at 15 and
20 µM) were bath-applied. To check the data for concentration-dependent effects, one-
way ANOVAs were applied to the data for every hippocampal subregion (DG, CA3, and
CA1) and drug. When the criteria of normal distribution and equal variance were not
met, a Kruskal-Wallis ANOVA on ranks was used (Figures 4.35A,B; 4.36A-C; 4.37A-C).
If the corresponding ANOVA reported statistical differences, t-tests were used to deter-
mine the different concentration(s) with significant change in FDSs at minutes 0 to 18 vs.
minutes 42 to 60 (Figure 4.25B).
All ADs tested (with the exception of 0.5 and 10 µM fluvoxamine and 1 and 10 µM ven-
lafaxine), did not affect DG-FDSs (Figures 4.34A; 4.35A,B; 4.36A-C; 4.37A-C; left panels
with bars in grey and white). In contrast, all ADs exerted enhancing effects on CA1-FDSs
in the same experiments (Figures 4.34A,D; 4.35A,B; 4.36A-C; 4.37A-C; right panels with
bars in black). Interestingly, the concentration dependence of this pharmacological effect
in CA1 is not uniform across drugs. Amitriptyline, clomipramine, and tranylcypromine
enhanced CA1-FDSs at one particular substance-specific concentration. Citalopram and
venlafaxine elevated neuronal network activity in CA1 at several concentrations and only
data sets obtained for fluoxetine and tianeptine are reconcilable with a classical dose-
response relationship. Furthermore, only tranylcypromine weakened CA1-FDSs at 0.1
µM (Figures ; 4.35A,B; 4.36A-C; 4.37A-C; right panels with bars in black and white). As
exemplarily tested for fluoxetine at a concentration of 10 µM, enhancing effects on HTC-
waves are preserved in CSDS mice (Figure 4.34B).
Direct axonal projections from EC to areas CA3 and CA1 are functionally inactivated in
the HTC-wave assay (Figure 3.1A,B). Therefore, CA1 activity is solely driven by action
potential firing of CA3 pyramidal neurons. Effects of ADs may therefore not be restricted
to area CA1, but also take place in area CA3. Supporting this scenario, fluoxetine, ven-
lafaxine, and tianeptine also exerted enhancing effects (except for tranylcypromine in
area CA3; Figure 4.37C) on CA3-FDSs, with the same concentration dependency as ob-
served for CA1-FDSs (Figures 4.36A; 4.37A,B; middle panels with bars in black).
Neurotrophins and their receptors (Trk and p75NTR) have repeatedly been implicated in
the pathophysiology of SRPDs and as a key mediator of the therapeutic response to ADs.
Independent of their chemical structure and primary mechanism of action, all ADs and
lithium are known to rapidly activate TrkB receptors (Castrén et al., 2007). Accordingly, it
was tested if fluoxetine enhanced CA3- and CA1 FDSs in a TrkB receptor-dependent man-
ner (Castrén et al., 2007; Duman and Aghajanian, 2012). Therefore, the low-molecular
weight TrkB ligand ANA-12 was used in one set of pharmacological experiments (min-
imum time of incubation, 1h). ANA-12 has been shown to selectively prevent phos-
phorylation of TrkB receptors by BDNF highly effectively and potent at submicromolar
concentrations (Cazorla et al., 2011; Longo and Massa, 2013). In slices pretreated with
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ANA-12 enhancing effects of fluoxetine (10 µM) on CA3- and CA1-FDSs were abolished
(Figure 4.34A-D).
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Fig. 4.35. Tricyclic ADs enhance HTC-waves. (A,B) Effects of the tricyclic ADs amitriptyline and
clomipramine on DG-, CA3-, and CA1 FDSs (A, 0.1 µM = 8 slices/4 mice; 0,5 µM = 8 slices/4 mice; 1 µM =
8 slices/4 mice; 5 µM = 7 slices/4 mice; 10 µM = 7 slices/3 mice; 15 µM = 7 slices/4 mice; 20 µM = 8 slices/5
mice; B, 0.1 µM = 9 slices/5 mice; 0.5 µM = 12 slices/7 mice; 1 µM = 10 slices/6 mice; 5 µM = 10 slices/5
mice; 10 µM = 8 slices/5 mice; 15 µM = 9 slices/3 mice; 20 µM = 8 slices/4 mice). (A,B) §, one-way ANOVAs:
p = 0.002 for amitriptyline in CA1 and p = 0.02 for clomipramine in CA1; followed by paired t-tests: ?p <
0.05.
4.3. CIRCUIT-LEVEL MECHANISM OF ANTIDEPRESSANT DRUG ACTION 57
AD (SSRI)
Fluoxetine
0.1 0.5 1 5 10 15 20
Concentration (µM)
0.1 0.5 1 5 10 15 20
Concentration (µM)
0.1 0.5 1 5 10 15 20
Concentration (µM)
? ?
? ? ?
?
??
??
%
 c
h a
n g
e  
o f
 F
D
S  
a m
p l
i t u
d e
100
150
250
50
0
300
200
100
150
250
50
0
300
200
100
150
250
50
0
300
200
§
A DG CA3 CA1(EC)
#
IN OUT
AD (SSRI)
Citalopram
0.1 0.5 1 5 10 15 20
Concentration (µM)
0.1 0.5 1 5 10 15 20
Concentration (µM)
0.1 0.5 1 5 10 15 20
Concentration (µM)
????
%
 c
h a
n g
e  
o f
 F
D
S  
a m
p l
i t u
d e
100
150
250
50
0
300
200
100
150
250
50
0
300
200
100
150
250
50
0
300
200
B
§
AD (SSRI)
Fluvoxamine
0.1 0.5 1 5 10 15 20
Concentration (µM)
0.1 0.5 1 5 10 15 20
Concentration (µM)
0.1 0.5 1 5 10 15 20
Concentration (µM)
??
?
%
 c
h a
n g
e  
o f
 F
D
S  
a m
p l
i t u
d e
100
150
250
50
0
300
200
100
150
250
50
0
300
200
100
150
250
50
0
300
200
C
? ?
§§
Fig. 4.36. SSRIs enhance HTC-waves. (A-C) Effects of the SSRIs fluoxetine, citalopram, and fluvoxamine
on DG-, CA3- and CA1 FDSs (A, 0.1 µM = 8 slices/4 mice; 0.5 µM = 8 slices/4 mice; 1 µM = 8 slices/4 mice; 5
µM = 8 slices/4 mice; 10 µM = 7 slices/5 mice; 15 µM = 7 slices/4 mice; 20 µM = 7 slices/3 mice; B, 0.1 µM =
7 slices/4 mice; 0,5 µM = 9 slices/5 mice; 1 µM = 8 slices/4 mice; 5 µM = 10 slices/5 mice; 10 µM = 8 slices/5
mice; 15 µM = 8 slices/4 mice; 20 µM = 7 slices/3 mice; C, 0.1 µM = 8 slices/3 mice; 0,5 µM = 8 slices/5 mice;
1 µM = 8 slices/4 mice; 5 µM = 8 slices/4 mice; 10 µM = 8 slices/3 mice; 15 µM = 8 slices/3 mice; 20 µM
= 9 slices/4 mice). (A-C) #, Kruskal-Wallis ANOVA on ranks: p = 0.033 for fluoxetine in CA3; §, one-way
ANOVAs: p < 0.001 for fluoxetine in CA1; p = 0.049 for citalopram in CA1; p = 0.002 for fluvoxamine in DG;
p < 0.001 for fluvoxamine in CA1; followed by paired t-tests: ? p < 0.05; ?? p < 0.01.
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Fig. 4.37. Venlafaxine, tianeptine, and tranylcypromine enhance HTC-waves. (A-C) Effects of venlafaxine
(SSNRI), tianeptine (SSRE), and tranylcypromine (MAOI) on DG-, CA3-, and CA1 FDSs (A, 0.1 µM = 8
slices/4 mice; 0.5 µM = 10 slices/6 mice; 1 µM = 9 slices/4 mice; 5 µM = 8 slices/5 mice; 10 µM = 9 slices/5
mice; 15 µM = 8 slices/4 mice; 20 µM = 7 slices/5 mice; B, 0.1 µM = 7 slices/4 mice; 0,5 µM = 7 slices/4
mice; 1 µM = 7 slices/4 mice; 5 µM = 7 slices/4 mice; 10 µM = 7 slices/4 mice; C, 0.1 µM = 8 slices/4 mice;
0.5 µM = 10 slices/5 mice; 1 µM = 8 slices/4 mice; 5 µM = 8 slices/4 mice; 10 µM = 8 slices/4 mice; 15
µM = 13 slices/8 mice; 20 µM = 8 slices/4 mice). (A-C) #, Kruskal-Wallis ANOVA on ranks: p = 0.005 for
tranylcypromine in CA1; §, one-way ANOVAs: p = 0.021 for venlafaxine in DG; p = 0.002 for venlafaxine in
CA3; p < 0.001 for venlafaxine in CA1; p < 0.001 for tianeptine in CA3; p < 0.001 for tianeptine in CA1; p =
0.004 for tranylcypromine in CA3; followed by paired t-tests: ?p < 0.05 ; ??p < 0.01.
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4.3.2 Lithium, BDNF, and ketamine amplify HTC-waves
The HIP is severely damaged by stress (Kim and Diamond, 2002), accompanied by a pro-
nounced impairment of activity flow through the HTC (Figure 4.29). Recent evidence
suggests that failed function of distinct neuronal networks underlie SRPDs (Castrén,
2005). Thus, the AD drug-induced enhancement of activity flow through the HTC (Fig-
ures 4.35A,B; 4.36A-C; 4.37A-C; middle and right panels with bars in black) suggests
a common, circuit-level mechanism for compounds with AD potential, that counter-
acts the detrimental effects of chronic stress. To potentially provide further evidence
for this scenario, the mood stabilizer lithium and the neurotrophin brain-derived neu-
rotrophic factor (BDNF) were tested using the HTC-wave assay. Both substances exert
AD activity in animal models and/or humans (Cipriani et al., 2009; Nixon et al., 1994;
Shirayama et al., 2002; Worrall et al., 1979). Lithium, bath-applied at clinically relevant
concentrations (0.5 mM, 1 mM; Smith et al., 2011), readily enhanced CA1-FDSs while hav-
ing no effect on DG- and CA3-FDSs (Figure 4.38A). BDNF (0.4 nM; Kang and Schuman,
1995) enhanced CA3- and CA1-FDSs, while leaving DG-FDSs unaffected (Figure 4.38B).
A growing body of preclinical and clinical data demonstrates that single subanesthetic
doses of ketamine (NMDA receptor antagonist) rapidly (within hours) alleviate symp-
toms of SRPDs in animals and humans (Autry et al., 2011; Berman et al., 2000). This is of
particular interest since traditional ADs need chronic administration to become clinically
effective (Duman and Aghajanian, 2012). To check whether "slow" and "fast" acting ADs
share a common network level mechanism in the HIP, ketamine (20 µM, Autry et al.,
2011) was added to the superfusion medium in the recording chamber. Replicating the
findings from ADs, ketamine strongly enhanced CA3- and CA1-FDSs (Figure 4.38C).
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Fig. 4.38. Lithium, BDNF, and ketamine enhance HTC-waves. (A,B,C) Effects of lithium, BDNF and ke-
tamine on DG-, CA3-, and CA1 FDSs (A, 0,5 mM = 7 slices/3 mice; 1 mM = 7 slices/5 mice; B, 0.4 nM = 8
slices/4 mice; C, 20 µM = 8 slices/5 mice. (A,B,C); ? p < 0.05 (paired t-test); ?? p < 0.01 (paired t-test); ???
p < 0.001 (paired t-test).
4.3.3 Haloperidol and diazepam weaken HTC-waves
All substances previously tested (ADs, lithium,BDNF, and ketamine), share two impor-
tant characteristics: They have AD effects in animal models and/or humans (Cipriani et
al., 2009; Shirayama et al., 2002; Worrall et al., 1979), and they enhance HTC-waves (Fig-
ures 4.35A,B; 4.36A-C; 4.37A-C). To additionally investigate the pharmacology of drugs
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with no obvious AD potential (Airan et al., 2007; Rygula et al., 2008), the impact of the an-
tipsychotic haloperidol and the anxiolytic diazepam (allosteric modulator of GABAA re-
ceptor) on HTC-waves was examined. In contrast to ADs, lithium, BDNF, and ketamine,
haloperdiol and diazepam weakened DG-, CA3-, and CA1-FDSs at low micromolar con-
centration (Kornhuber et al., 1999; Rupprecht et al., 2009), in a manner reminiscent of a
classical dose-dependent relationship (Figure 4.39A,B; left, middle and right panels with
bars in white).
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Fig. 4.39. Haloperidol and Diazepam weaken HTC-waves. (A,B) Effects of haloperidol and diazepam on
DG-, CA3-, and CA1 FDSs (A, 0.1 µM = 8 slices/5 mice; 0,5 µM = 8 slices/5 mice; 1 µM = 6 slices/4 mice; 5
µM = 8 slices/5 mice; 10 µM = 8 slices/5 mice; 15 µM = 6 slices/4 mice; 20 µM = 6 slices/3 mice; B, 0.5 µM
= 7 slices/4 mice; 1 µM = 6 slices/3 mice). (A) §, one-way ANOVAs: p < 0.001 in the DG; p = 0.002 in CA3;
p = 0.005 in CA1; followed by paired t-tests: ? p < 0.05; ?? p < 0.01; ???p < 0.001; (B) ?? p < 0.01 (paired
t-test); ??? p < 0.001 (paired t-test).
4.3.4 Fluoxetine modulates LTP of HTC-waves
ADs acutely enhance activity flow through the HIP, but may also modulate HTC-wave
efficacy on longer time scales and thus, persistently counteract SRPD associated cognitive
dysfunction (Sapolsky et al., 1986). Therefore, the impact of ADs on neuronal plasticity
was examined in the experimental setting used for pharmacological investigations (see
4.1.4 and Figure 4.25A). To reliably compare neuronal activities across slices, the last CA1-
FDS was set within narrow limits (0.15-0.18% ∆F/F) and six pulses at 5 Hz were applied
during control stimulations in all experiments (Figures 4.19). Again, the mean of the last
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FDSs out of three consecutive acquisitions was used as a final measure of DG, CA3, and
CA1 activity levels, and paired t-tests were employed to determine the intervention(s)
with significant changes in FDSs at minutes 0 to 18 (baseline) vs. the last 18 minutes af-
ter LTP induction or drug application. Following an initial period of stable HTC-wave
recordings, stimulation was stopped to apply a 6 second EC/DG-input train (5 Hz), gen-
erating network patterns which are capable of inducing LTP of synaptic transmission in
the HIP (Figures 4.20, 4.40A). Once stimulation with six control pulses at 5 Hz was re-
sumed, a potentiation of CA3- and CA1-FDSs was detected, which quickly returned to
baseline levels after a few minutes (Figure 4.40B). In a second set of experiments plas-
ticity induction was preceded by bath application of fluoxetine (5 µM) which strongly
amplified CA3- and CA1-FDSs, replicating previous findings (Figure 4.36A). If the 6 sec-
ond EC/DG-input at 5 Hz was applied after stable fluoxetine-mediated amplification of
HTC-waves, a significant LTP of HTC-waves above baseline levels was detected (Fig-
ure 4.40C). To investigate whether this observation depends on enhanced HTC-waves
or the sole presence of the drug, brain slices were preincubated with fluoxetine (5 µM)
for approx. 18 minutes, resulting in equal exposition times to fluoxetine in both sets of
experiments. In contrast to drug free experiments, the 6 second EC/DG-input at 5 Hz
also induced LTP of HTC-waves (Figures 4.40D). Importantly, DG-, CA3-, and CA1-FDSs
show equal activity levels during LTP induction across groups (Figure 4.40A). The DG
did not exhibit LTP and DG-FDSs significantly declined in all three experimental settings
(Figure 4.40A,B,C,D).
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Fig. 4.40. Fluoxetine modulates LTP of HTC-waves. (A) Quantification of neuronal activities in hippocam-
pal subregions in response to 5 Hz EC/DG-input (6 s.). (B) 5 Hz EC/DG-input (6 s.) failed to induce LTP of
HTC-waves. (C) Replicating results described above, 5 µM fluoxetine strongly enhanced HTC-waves (Fig-
ure 4.36A). Subsequent 5 Hz EC/DG-input (6 s) induced LTP of HTC-waves. (D) After preincubation of
slices with fluoxetine (5 µM, 18 min), 5 Hz EC/DG-input (6 s) likewise induced LTP of HTC-waves. (CTRL,
N = 6 slices/6 mice; FLX, N = 8 slices/8 mice; FLX CTRL, N = 6 slices/4 mice). (C,D) ?p < 0.05 (paired
t-test); ??p < 0.01 (paired t-test); ???p < 0.001 (paired t-test). Abbreviations: CTRL, control; FLX, fluoxetine.
Chapter 5
Discussion
5.1 Polysynaptic activity flow in the hippocampus
In accordance with the aims of the present thesis, it was first tested whether evoked
synaptic input from the entorhinal cortex to the dentate gyrus (EC/DG-input) triggers
hippocampal network dynamics, allowing the investigation of several aspects of polysy-
naptic activity flow within this limbic brain structure. For this purpose, VSDI was ap-
plied to mouse brain slices, enabling the direct investigation of neuronal activity on a
millisecond time scale, with a micrometer-range spatial resolution and a scope spanning
the entire HIP (Airan et al., 2007; von Wolff et al., 2011). In contrast to single pulse stimu-
lation of the PP, synchronous 5 Hz spike trains highly effectively induce neuronal activity
waves, which percolate through the entire trisynaptic circuit of the HIP. These so-called
"HTC-waves" precisely follow the rhythm of the EC/DG-input, drive high-frequency fir-
ing (>100 Hz) of CA3 pyramidal neurons, and induce NMDA receptor-dependent CA1
LTP within a few seconds. Moreover, the "HTC-wave assay" emerged as a valuable tool
to investigate drug effects on hippocampal network dynamics. Bath application of neu-
romodulators (CORT, CRH) and the cognitive enhancer caffeine rapidly boosts HTC-
waves.
5.1.1 5 Hz EC/DG-input induce polysynaptic activity flow through the hip-
pocampus
The effective induction of HTC-waves using 5 Hz EC/DG-input, is in line with the hy-
pothesis that such coordinated activity across neuronal cell ensembles represents a fun-
damental property of the entorhinal-hippocampal complex (Buzsàki, 2002). In the in-
tact brain, theta oscillations are thought to facilitate information transfer within neuronal
networks, leading to the formation and correct recall of explicit memories, and previous
research links their disturbance to the pathophysiology of SRPDs (Pernía-Andrade and
Jonas, 2014; Buzsàki, 2002; Linkenkaer-Hansen et al., 2005; Lega et al., 2012; Rutishauser
et al., 2010; Winson, 1978). It is assumed that the EC is fed with polymodal sensory infor-
mation (Watson et al., 2011) and, indeed, recently published in vivo data suggests that the
EC layer II stellate cell population activity is characterized by strong spike phase-locking
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to the local theta field potential during spatial navigation (Burgalossi et al., 2011; Fernan-
dez et al., 2013; Mizuseki et al., 2009; Quilichini et al., 2010). Moreover, several inher-
ent properties of the DG-CA3 network favors excitation of principle neurons over their
inhibition via GABAergic interneurons in a theta-frequency-dependent manner (Pernía-
Andrade and Jonas, 2014; Mizuseki et al., 2009; Scharfman et al., 1990; Thompson and
Gähwiler, 1989). In vivo recordings suggest that EC theta oscillations are tightly associ-
ated with theta-frequency discharges in DG granule cells (Jung and McNaughton, 1993;
Mizuseki et al., 2009; Skaggs et al., 1996). This hypothesis was recently validated by
means of recordings from intracellulary labeled granule cells (Pernía-Andrade and Jonas,
2014). Thereunto, in contrast to single action potentials, theta frequency trains in presy-
naptic MFs increase the discharge probability of CA3 pyramidal neurons (Henze et al.,
2002; Hsu, 2007; Mott and Lewis, 1992; Scharfman et al., 1990; Thompson and Gähwiler,
1989). Different mechanisms within the CA3 principal neuron-interneuron circuitry have
been reported to mediate such an "activity-dependent disinhibition" (Scharfman et al.,
1990; Mott and Lewis, 1992). These studies suggest that a decrease of inhibitory postsy-
naptic currents in CA3 pyramidal neurons after repetitive stimulations results from an
increase of the intracellular Cl− concentration, accompanied by a shift in its reversal po-
tential which leads to a decrease in driving force for chloride-mediated GABAergic inhi-
bition. Previous research also found a GABAB receptor-mediated reduction of presynap-
tic GABA release probability (Hsu, 2007; Mott and Lewis, 1992; Thompson and Gähwiler,
1989). Although, DG granule cells provide the main input onto GABAergic interneurons
situated in CA3 SL and thereby conferring net inhibition of the hippocampal CA3 net-
work after activation of the MF pathway (Henze et al., 2000; Mori et al., 2004). This sug-
gests a switch to net excitation in a (theta)frequency-dependent manner. Together with
simultaneously occurring frequency depression at MF synapses onto CA3 inhibitory in-
terneurons, suprathreshold EPSPs in CA3 pyramidal neurons are likely to occur (Toth et
al., 2000).
Here, the strong facilitation of MF onto CA3 pyramidal transmission likely took ad-
vantage of these network characteristics and is presumably such strongly pronounced
that even unitary EPSPs are able to fire CA3 pyramidal neurons (Henze et al., 2002;
Jonas et al., 1993; Toth et al., 2000). The recently reported involvement of membrane de-
rived lipids as retrograde messengers in facilitation of MF synaptic transmission (Carta
et al., 2014) is unlikely to occur during the induction of HTC-waves, since the HTC re-
verted to its locked state after approx. 60 seconds, whereas MF to CA3 potentiation ob-
served by Carta et al. (2014) lasts several minutes. The pivotal role of the MF to CA3
synapse is in line with the observation that a selective shutdown of neurotransmission at
these synapses is associated with the disappearance of HTC-waves. Supporting evidence
comes from recordings in anesthetized mice (Stepan et al., 2012). 5 Hz PP stimulation
triggers pop spikes in CA1 with the same delayed and initially progressive appearance
and with comparable latencies to onset (∼ 18 ms) as the CA1 neuronal responses in the
in vitro experiments. Moreover, HTC-waves are never observed if the PP is stimulated
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with 0.2 Hz and the occurrence and strength of activity propagations through the HTC
critically depends on the frequency and persistency of EC/DG-input (Figures 4.4, 4.4).
This previous research on this brain area, links neuronal network dynamics in the DG
with a gate or basic filter mechanism at the entrance to the HIP, modulating or filtering in-
coming information from the EC (Andersen et al., 1966; Ewell and Jones, 2010; Hsu, 2007;
Iijima et al., 1996; Scharfman et al., 1990). These considerations are supported by the ob-
servation that DG-FDSs increasingly decline in their magnitude during 0.2, 1, 5, and 20
Hz EC/DG-input, respectively (Figure 4.4). Similarly, Andersen et al. (1966), who placed
intracellular- and extracellular recording electrodes into the DG of rabbits to study its
activation after PP stimulation, also found induction EPSPs after a few seconds of repeti-
tive stimulation, with the highest degree of facilitation around theta and nearly abolished
signals at frequencies above 10 Hz (Andersen et al., 1966). Using VSDI, Iijima et al. (1996)
showed that only repetitive stimulation at 1 Hz or several reverberations of bicuculline-
induced excitation in the EC resulted in invasion of activity into area CA3, even if their
pharmacologically induced excitation is reminiscent of epileptic-like activity sometimes
observed in the present study (Figure, 4.9, Figure 4.10A). However, comparable to the
situation in the CA3 network, the switch from inhibition to excitation is likely mediated
by disinhibition of granule cells in response to repeated activation (Scharfman et al., 1990;
Thompson and Gähwiler, 1989). In combination with the fact that facilitation at MF
synapses develops stronger with higher frequencies (Toth et al., 2000), it is tempting to
speculate that the DG-CA3 complex acts as a "low-order band-pass filter," in which the
DG circuitry serves as the "low-pass unit" and the CA3 MF system as the "high-pass de-
vice." All this might explain, why the DG network is effectively passed by simultaneously
and repetitive incoming information encoded in the theta-frequency range. Hence, an
important physiological function of theta-rhythmical spiking of EC stellate cells might be
to drive sensory information through the whole entorhinal-hippocampal loop, but only
information presented for sufficient time and carried at certain frequencies might pass.
Moreover, the strengthening of HTC-waves by caffeine suggests that the amount of in-
formation flow is modifiable by attention enhancing drugs (Nehlig, 2010).
5.1.2 HTC-waves induce CA1 LTP
Beside effective gating of HTC-waves, the pronounced frequency facilitation at the MF
to CA3 synapse may promote action potential firing in CA3 pyramidal neurons and,
thus, is very likely responsible for the subsequent formation of CA1 LTP. Here, the oc-
currence of multiple pop spikes in CA3 SL in response to 5 Hz EC/DG-input is in line
with reports from intracellular recordings demonstrating that CA3 pyramidal neurons
typically respond with burst spiking (100-300 Hz) to suprathreshold depolarizations (An-
dersen et al., 2006; de la Prida et al., 2006). Previous research support the finding that
burst activity of CA3 pyramidal neurons triggers the formation of CA1 LTP (Bliss and
Collingridge, 1993; Buzsàki et al., 1987; Larson and Lynch, 1986). Buzsàki et al. (1987)
induced high frequency spiking of CA3 pyramidal neurons through local application
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of bicuculline, whereas other studies demonstrated that CA1 LTP is evoked most effec-
tively by theta-burst stimulation of CA3 to CA1 projections (Bliss and Collingridge, 1993;
Larson and Lynch, 1986).
Several lines of evidence suggest that DG granule cells are characterized by a sparse fir-
ing (Pernía-Andrade and Jonas, 2014; Leutgeb et al., 2007; Schmidt et al., 2012), which is
in contrast to the widespread activation of all hippocampal subfields in response to theta-
rhythmical EC/DG-input. However, the inherent properties of the entorhinal-hippocampal
network, in particular the gradual decrease of HTC-wave amplitude in response to a
stepwise reduction of EC/DG-input and the results from recordings of individual cell
pairs (Mori et al., 2004), suggest that activity percolations through the HTC and the con-
comitant induction of CA1 LTP also naturally take place at the level of a sparsely active
hippocampal network (Jung and McNaughton, 1993; Leutgeb et al., 2007; Whitlock et al.,
2006). The critical role of the HTC in learning and memory is supported by a recent study
providing evidence that some forms of HIP-dependent learning require the integrity of
the full HTC (Daumas et al., 2009; Nakashiba et al., 2008). In the first study, a transgenic
mouse line that permits selective shutdown of CA3 output displayed deficits in contex-
tual and spacial learning tasks (Nakashiba et al., 2008). Pharmacological suppression of
MF to CA3 synaptic transmission likewise impairs HIP-dependent learning tasks (Dau-
mas et al., 2009). However, these findings do not exclude contributions of other afferent
inputs. (e.g., direct EC input to area CA3 (Tsukamoto et al., 2003) and CA1 (Remondes
and Schuman, 2004) to CA1 LTP formation , but ascribe a major role to the HTC.
It was also shown that activity propagations through the HTC occur during 1 and 20 Hz
EC/DG-input. Although these frequencies were not tested with regard to their potential
to induce synaptic plasticity, it is likely that such EC/DG-input can also elicit CA1 LTP.
However, the present data and a previous study (Capocchi et al., 1992) suggest a more
effective induction of CA1 LTP in response to theta-rhythmical EC/DG-input. Theta fre-
quency EC/DG-input elicits a markedly higher strength of HTC-waves than any other
stimulation pattern (Figure 4.4). Second, the observations that 10 HTC-waves caused
no formation of CA1 LTP (Figure 4.4) and 30 stimuli were inefficient to evoke LTP of
HTC-waves in the absence of fluoxetine (Figure 4.40B,D), suggests an induction thresh-
old for long-term synaptic plasticity in the HIP, that might be merely reached through
inappropriate activation of the HTC. Finally, Capocchi et al. (1992) show that theta-burst
stimulation of CA3-CA1 projections leads to considerably stronger CA1 LTP than 1 and
20 Hz burst stimulation.
The present study confirms previous research (Buzsàki, 1988; Nakagami et al., 1997) on
"polysynaptic induction of LTP" in the CA1 subfield of the HIP, but provides more di-
rect evidence for this phenomenon. There are significant differences between the present
work and the studies from Buzsàki and Nakagami et al.. In particular, there are some
methodological caveats, which question the validity of previous results. Buzsàki re-
ported a long-lasting enhancement of CA1 population spikes in response to several high-
frequency (400 Hz) trains of stimuli delivered to the angular bundle. With regard to the
proposed function of the DG as a low-pass filter and the literature showing that high
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frequency input cause prominent inhibition of DG granule cells (Andersen et al., 1966;
Mott and Lewis, 1992; Scharfman, 1991) it is questionable whether any activity enters the
CA subfields via the trisynaptic pathway. Indeed, Buzsàki recognized that hippocam-
pal neurons are not able to follow high-frequency PP activity and that therefore the HTC
as a main route of information flow through the HIP (Andersen et al., 2006; Nicoll and
Schmitz, 2005; Neves et al., 2008) is effectively shut down. For this reason, he states
that direct EC-inputs to areas CA3 and CA1, which were functionally inactivated in this
study, most likely played an essential role in the induction of the population spike LTP
in area CA1. Moreover, it is questionable if 400 Hz spiking represents an physiological
activity pattern of any EC neuron that sends projections via the PP to the HIP (Andersen
et al., 2006; Pernía-Andrade and Jonas, 2014; Burgalossi et al., 2011; Mizuseki et al., 2009;
Quilichini et al., 2010).
In the second study, Nakagami et al. (1997) used voltage-sensitive dyes to monitor neu-
ronal activity in rat brain slices and report that a 1-s-long high-frequency (100 Hz) train
of pulses delivered to the dendritic field (ML) of the DG caused "trisynaptic LTP in-
duction." However, it is again questionable how effectively such a stimulation pattern
induces spiking of DG granule cells, in consideration of the effective blocking of high
frequency excitation from the EC (Andersen et al., 1966; Mott and Lewis, 1992). Further-
more, the probable contribution of changed neurotransmission at direct PP-input to CA3
pyramidal neurons and non-synaptic excitation of DG granule cells remains elusive. Ad-
ditionally, the authors provide no clear evidence of LTP at CA3 to CA1 synapses. In the
present study, this methodological problem was circumvented by showing an increase
of CA1 responses through direct stimulation of the SC-commissural pathway and by in-
hibiting CA1 LTP formation via a locally restricted blockade of NMDA receptors in area
CA1 (Figure 4.22).
5.1.3 Pharmacological modulation of HTC-waves
Beside their capacity to induce CA1 LTP, HTC-waves might be a valuable tool for study-
ing drug effects on polysynaptic activity flow through the HIP. Strong experimental ev-
idence suggest that caffeine exerts memory enhancing effects in animals and humans
(Borota et al., 2014; Kopf et al., 1999; Nehlig, 2010). Kopf et al. (1999) reported facilita-
tion of memory consolidation in rats when caffeine was administered after performing
a passive avoidance task. Similar results come from a recent study, demonstrating that
caffeine specifically enhanced memory consolidation in humans, when given within a
time-frame of 24 h after a behavioral discrimination task (Borota et al., 2014). For this
reason, the cognitive enhancer caffeine was added to the superfusion medium at a con-
centration found in the cerebrospinal fluid of humans after intake of 1-2 cups of coffee (5
µM Fredholm et al., 1999). The alkaloid rapidly boosted HTC-waves, which might partly
underlie its beneficial action on cognitive processes, although it is not known whether
HTC-waves also occur during memory consolidation (Borota et al., 2014; Kopf et al., 1999;
Nehlig, 2010). The mechanisms by which caffeine enhanced HTC-waves remains to be
determined. However, the antagonistic action of caffeine on adenosine A1 receptors is a
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strong candidate (Kukley et al., 2004). Pharmacological blockade of these receptors exerts
caffeine like effects on memory consolidation in behaving rats (Kopf et al., 1999) and was
reported to strengthen neurotransmission at MF to CA3 and SC to CA2-synapses (Kukley
et al., 2004; Simons et al., 2012). In addition, previous studies suggest the contribution of a
caffeine-induced form of CA1 LTP (Martín and Buño, 2003). However, the disappearance
of the caffeine-mediated effect on HTC-waves within approximately 15 min after remov-
ing the substance from the bath solution does not support the involvement of long-term
synaptic changes. This discrepancy might be related to the high caffeine concentration
(10 mM) used by Martín and Buño.
Furthermore, it was demonstrated that the stress hormones CORT (100 nM) and CRH (5
and 50 nM) also quickly amplified HTC-waves. As already suggested for caffeine, this
effect might contribute to enhanced cognitive functions in response to acutely elevated
stress hormone levels, i.e. in stressful situations (Blank et al., 2002; de Kloet et al., 1999).
Previous research demonstrates various acute effects of CRH on neuronal function in the
HIP (Blank et al., 2002; Hollrigel et al., 1998; Kratzer et al., 2013), but the underlying mech-
anisms are poorly understood. Complicating the picture, contrasting effects on neuronal
excitability were reported (Blank et al., 2002; Sheng et al., 2008). In recent years, CRHR1
emerged as a crucial mediator of CRH effects on hippocampal physiology (Kratzer et
al., 2013; Refojo et al., 2011; von Wolff et al., 2011). The rapid effect of CRH (50 nM) on
HTC-waves corroborates the results from a recent VSDI study (von Wolff et al., 2011).
von Wolff et al. (2011) demonstrate that the modulatory effect of CRH is abolished in
CRHR1 receptor knockout mice (von Wolff et al., 2011). Although von Wolff et al. evoked
activity percolations through the HIP non-synaptically by direct stimulation of the DG
granule cell layer, the similar activation pattern in downstream regions suggests that
HTC-wave amplification likewise requires intact CRHR1 receptor function (von Wolff et
al., 2011). This is of specific interest since CRHR1 deficient mice are impaired in spatial
recognition memory (Contarino et al., 1999). Strikingly, a considerably lower concentra-
tion (5 nM) of CRH than usually used in vitro (Kratzer et al., 2013; Refojo et al., 2011;
von Wolff et al., 2011) was still sufficient to modulate HTC-waves. This finding suggests
the HTC-wave assay to be highly sensitive to pharmacological modifications.
Several lines of evidence indicate that CORT facilitates hippocampal excitability via ge-
nomic (GRs) and non-genomic (MRs) mechanisms (de Kloet et al., 1999), although op-
posing actions were also reported, e.g., non-genomic GR-mediated modification of in-
hibitory networks in the HIP, that cause an increase in inhibitory postsynaptic currents
in CA1 pyramidal neurons (Hu et al., 2010). However, previous work indicates that the
rapid effects of CORT cannot be explained by genomic effects (Groeneweg et al., 2011;
Karst et al., 2005). First evidence for such a scenario came from Karst et al. (2005), demon-
strating enhanced miniature excitatory postsynaptic current (mEPSC)s in area CA1 after
bath application of 100 nM CORT in wild-type mice, an effect that was preserved in brain
specific GR knockout’s, but not in animals without MR receptors (Karst et al., 2005). Fur-
thermore, pharmacological activation of GRs did not increase mEPSC frequency, whereas
the MR agonist aldosterone (higher affinity for MR receptors) has pronounced effects
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(Karst et al., 2005). The present data gives support for such a rapid, non-genomic CORT-
mediated modulation of the hippocampal network (Karst et al., 2005).
Yet, independent from the underlying mechanism, the present findings suggest that CRH
and CORT are able to rapidly increase hippocampal output (Groeneweg et al., 2011).
From this it is tempting to speculate that both stress hormones positively modulate the
fast, inhibitory feedback onto the HPA axis (Radley, 2012).
An issue not addressed in this study was whether LTP formation plays a causal role in the
CRH and CORT-induced enhancement of HTC-waves (Blank et al., 2002; Wiegert et al.,
2006) However, the fast facilitation under moderate PP stimulation (Figures 4.24C, 4.26)
is an argument against the contribution of a long-term plasticity-dependent change in
glutamatergic neurotransmission, but rather a CRHR1-mediated enhancement of neu-
ronal excitability and a non-genomic mineralocorticoid receptor-mediated increase in
glutamate release probability, respectively (Groeneweg et al., 2011; Karst et al., 2005;
von Wolff et al., 2011).
It is important to note that the acute application of all drugs tested here, shares one impor-
tant similarity. They shape neuronal function via diverse cellular mechanisms (Nehlig,
2010; Joëls, 2006; Maras and Baram, 2012), thus rendering the prediction of their impact
on the neuronal network level practically impossible. In contrast, the HTC-wave assay
integrates all cellular adjustments in response to pharmacological intervention and re-
ports the "net" outcome.
Taken together, the present results describe for the first time that theta-rhythmical stimu-
lation of PP fibers is sufficient to induce polysynaptic activity flow within the HIP. This
activity likely reflects synchronous spiking of EC stellate cells (including grid cells (Bur-
galossi et al., 2011; Hafting et al., 2008) and the resultant HTC-waves trigger CA1 LTP
within a few seconds. Moreover, this approach proved to be a valuable tool for studying
drug effects on neuronal network dynamics. On that account, HTC-waves might be use-
ful to examine polysynaptic activity flow through the HIP in animal models of disease.
5.2 HTC-waves and stress
After the development and validation of the HTC-wave assay, it was found that chronic
stress impairs polysynaptic activity flow through the HIP. To compare VSDI signals, the
HTC-wave assay was refined by normalizing the EC/DG-input strength, using a specific
ROI in the DG (DGS-ROI; Figure 4.27). Initial studies revealed a linear relationship be-
tween DGS-, CA3-, and CA1-FDSs in a given stimulus range. Although, DGS-FDSs were
nearly identical in CTRL vs. CSDS animals, stimulation intensities to evoke predefined
DGS-FDSs were significantly higher in CSDS mice. The most obvious finding to emerge
from these experiments was that CA3- and CA1-FDSs were markedly decreased in CSDS
mice. In addition, these differences were stable over the entire time of experimentation
(6 days with ongoing defeat for prospective animals), suggesting a stable pattern of hip-
pocampal adjustments after two weeks of CSDS.
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5.2.1 CA3- and CA1-FDSs increase linearly with increasing DGS-FDSs
Analogous activation pattern at the input region of the HTC turned out to be vital to
reliably detect downstream stress effects in CSDS mice (Airan et al., 2007; Kim et al.,
2012). However, the occurrence of HTC-waves is very likely not uniform across slices.
Previous research has documented adverse modifications of EC principle cells in re-
sponse to chronic stress, which could possibly lead to structural adjustments, includ-
ing axonal arborizations (Lucassen et al., 2001; Cooper et al., 2009). Such alterations
might bias electrical stimulation of the PP. Differences in the electrode position and,
thus, the number of recruited fibers and/or deviations of neuronal connectivity and
the extend of cut fibers of distinct neuronal populations in brain slices may also in-
crease the variability across experiments (Amaral and Witter, 1989; Andersen et al., 2006;
Jackson and Scharfman, 1996). Thus, it seems obvious that fixed voltage intensities or
percentage shares are not suited to generate equal activation patterns in all experiments.
This point is particularly relevant since voltage intensities which were capable of evok-
ing distinct FDSs in the DG, markedly differed between CTRL and CSDS mice. Initial
studies revealed normalization of neuronal activity in the DGS-ROI suited to fulfill the
requirement of equal input into the HTC. This was done using single pulse EC/DG-input
to evoke specific DGS-FDSs. In a wide stimulus range, FDSs within this particular ROI
were found to be linear with subsequent CA3- and CA1-FDSs in response to 15 pulses at
5 Hz (Figure 4.28B), a finding that was preserved in CSDS mice (Figure 4.30A).
The exact explanation for this observation remains to be determined. In this context,
it is important to note that anatomy and function is not homogenous along the trans-
verse axis of the DG. As mentioned above, the DG is divided into a suprapyramidal and
infrapyramidal blade (Andersen et al., 2006; Witter, 2007) and several anatomical differ-
ences between granule cells in both regions have been reported (Andersen et al., 2006;
Scharfman et al., 2002; Witter, 2007). For example, interaction between granule cells and
CA3 pyramidal neurons via the MF pathway depends on their position along the trans-
verse axis of the DG and HIP, respectively. Proximal CA3 cells are preferentially inner-
vated by neurons in the infrapyramidal blade, whereas granule cells in the suprapyra-
midal blade innervate CA3 pyramidal neurons along the entire transverse axis (Witter,
2007). Furthermore, inputs originating from different parts of DG also exert differential
influence along the dendritic tree of individual CA3 pyramidal neurons (Witter, 2007).
These anatomical findings are of specific interest because several studies found functional
differences along the transverse axis of the DG (Choi et al., 2003; Jaarsma et al., 1992;
Schmidt et al., 2012; Scharfman et al., 2002). For instance, Schmidt et al. (2012) inves-
tigated the expression of immediate early genes in rats after a spatial exploration task
and found that granule cells in the suprapyramidal blade were more active than in the
infrapyramidal blade. In another study, Scharfman et al. (2002) reported effects of epilep-
tic seizures on molecular and electrophysiological parameters in the two blades. Using
VSDI, they found a stronger spread of activity into the infrapyramidal blade, an obser-
vation that they associated with a more important role of the infrapyramidal blade in
activating hippocampal neurons. Despite the heterogeneity of these findings, they might
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account for the strong correlation of neuronal activity between the suprapyramidal blade
and areas CA3 and CA1.
5.2.2 Reduced activity flow through the hippocampus
Using the refined HTC-wave assay, the current study found that CSDS markedly reduced
the strength of polysynaptic activity flow through the HIP. This was very likely an effect
of the well documented adverse physical changes in the HIP in response to persistently
elevated stress hormone levels (Magarin¨os and McEwen, 1995; Sapolsky et al., 1986;
Sousa et al., 2000; Vyas et al., 2002). In this context, the HPA axis is most often rec-
ognized (Magarin¨os and McEwen, 1995; Nestler and Hyman, 2010; Sousa et al., 2000;
Vyas et al., 2002) since chronic stress paradigms consistently demonstrate elevated blood
levels of stress hormones, most frequently CORT and CRH (Herman et al., 1995; Makino
et al., 1995; Sousa et al., 2000; Wagner et al., 2011). Other issues are that the HIP seems
to be a major target of GCs, since its GC receptor expression is enriched (McEwen et
al., 1968), exogenous GC administration mimics adverse effects of chronic stress on hip-
pocampal structure and function (McEwen, 2001), and hippocampal efferents are thought
to inhibit emotional stress-induced HPA axis activation, via GC receptor-mediated neg-
ative feedback (McEwen and Gianaros, 2011; Jacobson and Sapolsky, 1991; Sapolsky et
al., 1984a). Supporting evidence comes from human studies, showing abnormal activity
of the HPA axis (hypercortisolism or hypocortisolism) and HPA axis insensitivity to GC
receptor agonist treatment (i.e., dexamethasone supression test) is observed in approxi-
mately one half of depressed individuals (Carroll et al., 1976; Holsboer, 1983; Krishnan
and Nestler, 2008). Accordingly, the CSDS paradigm has been shown to robustly induce
chronic stress parameters associated with HPA axis dysregulation, including increased
adrenal glands weight, reduced thymus weight, and increased basal plasma levels of
CORT (Hartmann et al., 2012; Wagner et al., 2011). The association of these adjustments
with human SRPDs corresponds well with evidence from behavioral experiments in ro-
dents. A minimum of 10 days CSDS (Berton and Nestler, 2006) results in a high anx-
iety phenotype, a reduction in exploratory behavior, an increased emotionality and a
decreased grooming behavior (indicated by reduced fur quality), which are supposed
to represent depression-like symptoms (Berton and Nestler, 2006; Hartmann et al., 2012;
Wagner et al., 2011).
No differences between groups were found in CA3-FDSs at the lowest stimulation inten-
sity. A possible explanation is that FDSs were such less pronounced that differences did
not come into effect. However, the trend towards higher activity levels in area CA1 is in
line with results obtained from stronger stimulation intensities.
In agreement with CSDS used here, various other animal models of chronic stress (e.g.,
chronic immobilization stress (CIS), chronic unpredictable stress (CUS), chronic mild
stress (CMS), chronic variable stress (CVS); Airan et al., 2007; Berton and Nestler, 2006;
Fuchs and Flúgge, 2003; Herman et al., 1995; Ulrich-Lai et al., 2006; Wagner et al., 2011)
applied to different species (mice, rats, tree shrews; Airan et al., 2007; Berton and Nestler,
2006; Fuchs and Flúgge, 2003; Wagner et al., 2011) have identified many of signaling
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molecules and receptors likely involved in neuronal response to prolonged stress ex-
posure (e.g., neuromodulators, neurotransmitters, neurotrophic factors; Duric and Du-
man, 2013). Furthermore, there are multiple forms of adjustments involved, ranging
from changes on the molecular level (Wagner et al., 2011) to cellular adaptions (Snyder
et al., 2011) to remodeling of principle neurons (Magarin¨os and McEwen, 1995; Figure
1.3). Likewise, stress-induced modification in the structure of the HIP may also play a
causal role in humans, since alterations in neurotrophin signaling (Dwivedi et al., 2005;
Knable et al., 2004), neuronal morphology (Kempton et al., 2011) and volume (Neumeis-
ter et al., 2005; Sheline et al., 2003) were observed in individuals suffering from SRPDs.
However, significant bias might be associated with the utilization of different animal
models (Nestler and Hyman, 2010). For example, Vyas et al. (2002) demonstrated that
two different animal models exhibit distinct chronic stress effects in the HIP. In their
study, only CIS caused the typical morphological adjustments in CA3 pyramidal neu-
rons, which was not detectable after CUS. This is in contrast to the observations made
by Sousa et al. (2000) and Magarin¨os and McEwen (1995) who reported significant alter-
ations in CA3 pyramidal neurons also in response to CUS. Similar inconsistencies across
animal models were also reported for adjustments of basal CORT levels and adrenal
glands weight (Herman et al., 1995; Magarin¨os and McEwen, 1995; Wagner et al., 2011).
Hence, more circuit-centered approaches might be better suited to integrate the diverse
physical changes in response to chronic stress (Airan et al., 2007; Karayiorgou et al., 2012).
In line with this suggestion, CSDS shares critical stress indices with other animal mod-
els. For instance, prominent indicators of chronic stress are baseline hypersecretion of
CORT and adrenal hypertrophy. Both were demonstrated after exposure to CSDS, CUS
and CVS (Herman et al., 1995; Magarin¨os and McEwen, 1995; Sapolsky et al., 1984b;
Wagner et al., 2011; Watanabe et al., 1992). These paradigms but also chronically admin-
istered CORT, have been shown to promote a reversible shortening and debranching of
apical and basal dendrites of CA3 pyramidal neurons (Magarin¨os and McEwen, 1995;
Watanabe et al., 1992; Vyas et al., 2002). In a recent study Numakawa et al. (2009) demon-
strated that chronic exposure to dexamethasone and CORT reduced TrkB-GR interaction,
BDNF-stimulated PLC-γ and BDNF-triggered glutamate release. In line with the study
of Numakawa et al. (2009), stress-induced glutamatergic dysfunction might be an under-
lying cause of hippocampal adjustments (Kallarackal et al., 2013; Moghaddam et al., 1994;
Lowy et al., 1993; Popoli et al., 2012). Numakawa et al.’s study might also explain reduced
neurotrophic factors (e.g., BDNF mRNA) in chronically stressed rodents (Murakami et
al., 2005). BDNF in turn maintains neuronal survival and morphology of hippocampal
neurons (Chao, 2003; Smith et al., 1995; Saarelainen et al., 2003) and is critically involved
in synaptic plasticity in vitro (Kovalchuk et al., 2002) and in vivo (Ying et al., 2002).
Furthermore, downregulation of GR mRNA in the HIP is also observed in response to
CSDS, CVS, and CUS likely attenuates the GC negative feedback, thereby exacerbating
CORT-induced adverse effects on neuronal morphology (Herman et al., 1995; Holsboer,
1983; Makino et al., 1995; Sapolsky et al., 1984b; Wagner et al., 2011).
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Finally, CSDS and CVS trigger CRH mRNA expression in the PVN (Herman et al., 1995;
Hartmann et al., 2012), which is associated with morphological changes of hippocam-
pal neurons, similar to those observed after prolonged exposure to high levels of CORT
(Chen et al., 2004; Duric and Duman, 2013).
From all this, it is possible to hypothesize that chronic stress-induced changes in hip-
pocampal physiology result in a circuit-level phenotype, independent from a common
etiology or mechanism (Airan et al., 2007; von Wolff et al., 2011).
Another important finding was that FDSs were severely reduced in both CA regions
under investigation. In this regard it is important to note that the approach presented
here aimed to explore circuit-level mechanisms of chronic stress in the HIP. VSDI together
with the methodology to induce polysynaptic activity flow within the HIP offers the
advantage to directly measure neuronal activity in large-scale neuronal networks and
compute input/output relationships (Airan et al., 2007; Avrabos et al., 2013; Ikrar et al.,
2013; Refojo et al., 2011; von Wolff et al., 2011). Although this approach can thereby
support data from indirect brain imaging techniques (e.g., fMRI), it was not deployed
to detect alterations on the cellular level and, consequently, it is not suited to quantify
the contribution of adverse stress effects in distinct neuronal subpopulations of the HIP.
Maladaptions in response to chronic stress are not restricted to area CA3 (Magarin¨os and
McEwen, 1995; Watanabe et al., 1992) and, although its effects on neurons in area CA1
are less well characterized (Kallarackal et al., 2013; Sousa et al., 2000), it is very likely that
adverse effects in both regions contribute to reduced HTC-waves in stressed mice.
As far as known, only two other studies employed VSDI in the HIP to gain evidence for
a network-level neurophysiological endophenotype in animal models (Airan et al., 2007;
Kim et al., 2012), but none of these studies investigated polysynaptic activity flow. Kim et
al. (2012) showed that knockdown of hyperpolarization-activated cyclic nucleotide-gated
1 channels (HCN1) in the dorsal CA1 region resulted in antidepressant behavior in the
forced swim test (FST) and was associated with a widespread increase of VSDI signals in
response to afferent stimulation of SC. The results of this research support the idea that
decreased hippocampal activity is associated with depression-like behavior (Kim et al.,
2012; Sheline et al., 2003).
However, Kim et al.’s and the present investigation differ from Airan et al.’s observa-
tion of enhanced neuronal activity in area CA1 in response to chronic stress (Airan et al.,
2007). Kim et al. (2012) hypothesized that this discrepancy might be related to the brain
region under study (ventral vs. dorsal, see discussion below), or the position of stimulus
electrode (SC vs. PCL; Kim et al., 2012). Here, this discrepancy most likely results from
a different experimental setup. In contrast to the HTC-wave assay, Airan et al. (2007)
evoked neuronal activity in stratum pyramidale of CA1. Since CA1 neuronal activity
predominantly depends on excitatory drive from CA3 pyramidal neurons, it seems im-
possible to predict the "net" outcome in CA1 without considering CA3. Similarly their
observation of reduced activity in the DG in the same experiments, rises the question
how reduced output from upstream DG could result in enhanced activity in downstream
CA1 (Airan et al., 2007). Moreover, there is a wealth of evidence showing that chronic
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stress has manifold detrimental effects in the HIP causing impairment in spatial naviga-
tion (Langston et al., 2010), memory formation (Whitlock et al., 2006), and HPA axis reg-
ulation (Radley, 2012), which is difficult to bring into conformity with enhanced output
from CA1 pyramidal cells or a generally enhanced neuronal activity in the CA1 network
(Kim et al., 2012). Support for Airan et al.’s findings comes from Kallarackal et al. (2013),
demonstrating no decrease of AMPA receptor-mediated excitation at SC to CA1 synapses
in chronically stressed rats. However, since multifarious adjustments result from chronic
stress (Smith et al., 1995; Sousa et al., 2000), a lack of association with AMPA-receptor-
mediated excitation does not exclude that other adverse changes in area CA1 contribute
to an overall diminished network activity. Direct axonal projections from EC to areas
CA3 and CA1 are functionally inactivated in the HTC-wave assay. Stimulation of direct
CA1-inputs by Airan et al. might explain the contradicting results. However, this is in
contrast to another finding from Kallarackal et al.’s study. They showed that chronic
stress reduced AMPA receptor-mediated excitation at PP to CA1 synapses, but again,
this does not exclude the implication of other, more pronounced effects which change the
"net" outcome.
Next to adjustments in the CA regions, it is important to consider alterations in the DG,
a significant factor associated with detrimental stress effects on HTC-waves. Although
the input normalization for group comparisons avert detection of chronic stress effects
by means of neuronal activity in the DG, the pronounced differences in stimulation in-
tensities between groups indicates an maladaptive hyperexcitability of the DG network.
Although it may be counterintuitive that hyperexcitability at the first tier of the HTC
reduces activity flow through the HIP, these results are in line with a recent report, in
which the authors used VSDI in an animal model of enhanced or reduced neurogenesis
(Ikrar et al., 2013). In recent years, neurogenesis has been increasingly recognized as an
possible mediator of stress-induced adverse changes in the HIP (Duric and Duman, 2013;
Gould and Tanapat, 1999; Santarelli et al., 2003; Snyder et al., 2011). Stress-induced de-
creases in proliferation of new neurons in the DG subgranular zone is well established,
supported by a number of different rodent and primate studies using various types of
stress models (Malberg and Duman, 2003; Snyder et al., 2011). Ikrar et al. (2013) demon-
strated a modestly increased excitability of the DG in mice in which adult neurogenesis
was ablated, likely compatible with the situation observed after chronic stress exposure
(Ikrar et al., 2013; Gould and Tanapat, 1999). However, this finding is again in striking
contrast to Airan et al. (2007) results, who found that VSDI signals in the DG were re-
duced after 3 weeks of CMS. Enhanced excitability of DG granule cells is thought to be
mediated by compensatory local circuit mechanisms such as reduced excitatory drive
onto inhibitory interneurons (Ikrar et al., 2013; Singer et al., 2011). Although, the manip-
ulations of hippocampal neurogenesis did not change the output from granule cells to
CA3 pyramidal neurons (Ikrar et al., 2013), it may have important implications for re-
duced activity flow through the HTC. Since granule cells predominantly exert inhibitory
influence onto CA3 pyramidal neurons (di-synaptic feed forward inhibition via SL in-
terneurons) a changed number of granule cells could greatly influence activation patterns
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of the CA3 network and subsequent activation of neurons in area CA1 (Ikrar et al., 2013;
Mori et al., 2004).
5.2.3 Functional implications of impaired HTC-waves
Impaired HTC-waves support previous research on the HIP, linking detrimental mod-
ifications after chronic stress with disturbed hippocampal function (Kim and Diamond,
2002; McEwen, 2001). Elevated stress-hormone levels, induced by chronic stress or exoge-
nously administered CORT, cause suppression of LTP in the HIP in vitro and in vivo (Al-
farez et al., 2003; Bodnoff et al., 1995; Foy et al., 1987; Kim et al., 1996; Pavlides et al., 2002;
Xu et al., 1997). Whereas LTP is compromised, the induction of LTD is facilitated both,
in vitro and in vivo (Kim et al., 1996; Xu et al., 1997). Consistently, chronically stressed
animals display deficits in HIP-dependent learning paradigms (Diamond et al., 1996).
This is in line with a impaired performance of humans in HIP-dependent memory tasks
observed after the administration of high doses of CORT (Newcomer et al., 1999) and in
depressed individuals (Burt et al., 1995).
Reduced activity flow through the HTC and the related decreased output from area CA1
in response to CSDS has not only important implications for cognitive processes, it might
also have negative consequences for termination of the neuroendocrine stress response
(Radley, 2012). A wealth of research links chronic stress and elevated GCs in the HIP to
disruption of the negative feedback control of the HPA axis, likely promoting a vicious
circle and further exacerbation of neuronal damage by excessive production of stress
hormones (see 1.3.1.1; Radley and Sawchenko, 2011; Radley, 2012; Jacobson and Sapolsky,
1991). However, several other limbic brain regions integrate stress responses by feedback
control of HPA axis activity as indicated by the observation that inhibitory influence is
not fully abolished in rodents with a lesioned ventral SUB (Radley, 2012).
Within this framework, a limitation of this study is that the experiments were conducted
in dorsal or intermediate parts of the HIP. Although pyramidal neurons in area CA1
are heavily connected to neurons in the subiculum (Amaral et al., 1991), the only rel-
evant extrinsic projections to the PVN arise from ventral parts of the HIP, in partic-
ular from the ventral subiculum (Amaral et al., 1991; Andersen et al., 2006). This is
consistent with the proposed functions of the ventral (stress and emotional reactions)
and dorsal (learning and memory, spatial navigation) HIP (Fanselow and Dong, 2010;
Moser and Moser, 1998). However, recent evidence supports the hypothesis that detri-
mental alterations in response to chronic stress also take place in the ventral zone. Haw-
ley and Leasure (2012) investigated the effects of CUS in the ventral and dorsal HIP.
They found that adverse effects on hippocampal physiology (e.g., neurogenesis) were
even more severe in ventral parts. Furthermore, several lines of evidence suggest that
the three parts of the HIP are not completely isolated from each other, rather they can
interact via several routes (Fanselow and Dong, 2010). One important connection is the
dorsal zone’s projections to the medial septal complex and supramammillary nucleus,
because both of these structures send projections back to the ventral HIP. In this way,
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pyramidal neurons situated in dorsal parts of area CA1 might gain access to the hypotha-
lamic network and, thus, HPA axis regulation (Fanselow and Dong, 2010). Finally, using
fMRI, Campbell and Macqueen (2004) showed reduced posterior hippocampal volume
in depressed humans (dorsal HIP in rodents), suggesting that the posterior HIP might be
involved in stress associated functions.
5.2.4 Stress effect on HTC-waves is independent from the day of testing
Although CSDS was not stopped after 2 weeks (see 3.1.1), the reduction of FDSs in areas
CA3 and CA1 were stable over the entire time of experimentation (6 days). This indicates
that detrimental changes in the HIP were present after 14 days of defeat, but this does not
exclude the occurrence of additional or more severe alterations of HTC-waves in response
to longer periods of stress.
This finding corroborates previous research showing that CSDS robustly increased stress
parameters in the HIP after 10 days (Berton and Nestler, 2006; Hartmann et al., 2012;
Wagner et al., 2011). However, it is important to note and demonstrated in this study
(Figures 4.24C, 4.26, 4.31) that the effects of stress and its mediators are highly variable
along a continuum of temporal domains, with frequently opposing modifications in re-
lation to the period of stress exposure (de Kloet et al., 2005; Karst et al., 2005; Magarin¨os
and McEwen, 1995).
In summary, refinement of the HTC-wave assay proposes a high-speed imaging ap-
proach to compare polysynaptic activity flow through the HIP in animal models of dis-
ease. While it was speculated that adverse changes of hippocampal structure and func-
tion induced by chronic stress resets input/output relationship (Pavlides et al., 2002), a
direct demonstration was missing until now. Moreover, these data suggest impaired ac-
tivity flow through the HTC, a common circuit-level phenotype of stress-related adjust-
ments in the HIP. This stress-induced dysfunctional hippocampal network may in turn
impair the acquisition of new information and negative feedback on HPA axis activity
and, thus, lead to cognitive deficits and elevated stress hormone levels that are common
in SRPDs. This circuit-centered approach might help, to bridge the gap between molecu-
lar, cellular, and morphological changes to behavioral alterations.
5.3 Antidepressant drug action in the hippocampus
The data of the last section points to a shared, circuit-level mechanism of AD drugs in
the HIP that works in the opposite direction of chronic stress. The HTC-wave assay in
combination with bath application of diverse classes of ADs at low micromolar and high
nanomolar concentrations shows that all of them acutely increase the strength of HTC-
waves in wild-type and, as exemplary tested for fluoxetine, also in chronic social defeat
stress (CSDS) mice. Notably, this effect is not present at 100 nM and in most cases also
not at 500 nM, suggesting an monoaminergic system-independent effect. Moreover, the
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mood stabilizer lithium, the neurotrophin BDNF and the anesthetic ketamine exert sim-
ilar modifications, whereas the antipsychotic haloperidol and the anxioloytic diazepam
weaken activity percolations through the HIP. Fluoxetine not only enhances HTC-waves
rapidly, but is also capable of facilitating LTP of activity percolations through the HIP.
Finally, the TrkB receptor ligand ANA-12 blocks the fluoxetine-induced modifications of
HTC-waves.
5.3.1 Antidepressants enhance HTC-waves
The present results show that tricyclic ADs (amitriptyline, clomipramine), SSRIs (citalo-
pram, fluoxetine, fluvoxamine), SSNRI (venlafaxine), MAOI (tranylcypromine), and SSRE
(tianeptine) acutely enhance neuronal activity waves on the way from the classical hip-
pocampal input region (DG) to an important output region of the HIP (CA1) at ther-
apeutically relevant concentrations (Bolo et al., 2000; Couet et al., 1990; Strauss et al.,
1997), irrespective of their pharmacological classification (Richelson, 2001). Together
with the finding that fluoxetine is able to facilitate LTP of HTC-waves, this supports
the hypothesis that drugs with AD potential cause a rapid and sustained elevation of
hippocampal output, linking AD action to a common circuit-level phenotype that coun-
teracts the chronic stress-induced hippocampal impairment (Airan et al., 2007; Kim et
al., 2012; Maya Vetencourt et al., 2008; Sapolsky et al., 1986; von Wolff et al., 2011). As
already discussed in the previous section, experiments were conducted in dorsal or in-
termediate parts of the HIP, whereas ventral parts are thought to be primarily involved
in brain function associated with emotion and stress (Fanselow and Dong, 2010) and
some potent candidate mechanisms (e.g., neurogenesis) for "network" actions of ADs
were attributed to this hippocampal segment (Airan et al., 2007; Banasr et al., 2006;
Fanselow and Dong, 2010). However, the acute amplification and LTP of HTC-waves
by ADs is very unlikely to be mediated by the addition of new cells in the DG, be-
cause newly generated granule cells are not considered to contribute to hippocampal
physiology before 4 weeks of age (Snyder et al., 2009). Two scenarios might explain
the observed effects of ADs on HTC-waves with respect to a functional differentiation
of the HIP along its septotemporal axis. First, the same repeating lamellar organiza-
tion, together with the same serial trisynaptic connectivity throughout the entire HIP,
suggests that ADs may have similar effects in brain slices from ventral parts of the HIP
(Andersen et al., 2006) or, in contrast, ADs produce inverse effects with respect to differ-
ent memory functions (e.g., ventral = emotional memory vs. dorsal = spatial memory)
that should also be inversely modulated during pharmacological treatment (Fanselow
and Dong, 2010). Unfortunately, this hypothesis is difficult to prove since HTC-waves
are most reliably generated in slices from the dorsal HIP and very limited data on ef-
fects of ADs in the dorsal vs. the ventral zone of the HIP is currently available. Second,
emerging evidence suggests dorsal parts of the HIP to be involved in the pathophysi-
ology of SRPDs and to serve as an important site of action for ADs, thereby inhibiting
pathological hypoactivity (see 5.2.3; Campbell and Macqueen, 2004; Gould et al., 2007;
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Kim et al., 2012). In line with this, genetic modulation of ion channel function in the dor-
sal HIP has been associated with AD action in animal models (Kim et al., 2012). By using
VSDI, Kim et al. show that enhancement of dorsal hippocampal activity by knockdown
of HCN1 channels leads to AD-like behaviors in mice (Kim et al., 2012). Interestingly,
this was associated with a upregulation of BDNF (see discussion below).
A core symptom of many SRPDs and corresponding animal models is reduced cognitive
performance including an impairment of HIP-dependent memories (e.g., spatial and ex-
plicit memory; Campbell and Macqueen, 2004; Gould et al., 2007; Pittenger and Duman,
2008; Song et al., 2006), which is strongly associated with dorsal hippocampal function
(Krishnan and Nestler, 2008; Morris et al., 1986; Tsien et al., 1996). Consistently, animal
models of SRPDs exhibit facilitated LTD and blocked LTP in area CA1, both in in vitro and
in vivo (Foy et al., 1987; Kim et al., 1996; Shors et al., 1989; Xu et al., 1997). Studies inves-
tigating the acute effects and chronic administration of ADs on HIP-dependent cognitive
functions in patients (respectively animal models of SRPDs) and healthy volunteers (re-
spectively wild type animals) have produced contradicting results (Harmer et al., 2009;
Holderbach et al., 2007; Keith et al., 2007; Mowla et al., 2007; Shakesby et al., 2002;
Stäubli and Xu, 1995; Vouimba et al., 2006; Vythilingam et al., 2004). For instance, acute
application of tianeptine and fluoxetine in vivo were found to inversely modulate CA1
LTP (Shakesby et al., 2002). Only tianeptine was able to reverse stress-induced impair-
ment of CA1 LTP, whereas fluoxetine blocked this effect, a finding that is attributed to a
differential modulation of monoaminergic signaling by these drugs (Shakesby et al., 2002;
see discussion below). At least for animal experiments, these controversial results might
be related to methodological issues, since no previous study incorporated the entire hip-
pocampal network instead of isolated subregions or synapses (Holderbach et al., 2007;
Von Frijtag et al., 2001; Keith et al., 2007; Shakesby et al., 2002). Since fluoxetine ex-
erts strong effects on CA3 activity (Figure 4.36; Kobayashi et al., 2008), it would also
be interesting to investigate fluoxetine effects on MF to CA3 synaptic transmission in
Shakesby et al.’s study. However, these mixed results are not supported by the present
data, rather they suggest a circuit-level effect of ADs facilitating LTP in the HIP. To-
gether with the observation that acute effects are also present in CSDS mice, this sug-
gests that ADs may counteract SRPDs-related malfunction of cognitive abilities via en-
hanced neuronal activity flow in the HIP, but also improve cognition in healthy sub-
jects (Mowla et al., 2007). In contrast to hampered activity percolations in response to
CSDS, enhanced hippocampal activity after AD treatment may positively influence the
activity of the amygdala, prefrontal cortex, hypothalamus, and other brain structures as-
sociated with the pathophysiology of SRPDs and, thus, restore normal activity patterns
in disease-related brain networks, including the HPA axis (Castrén, 2005; Radley, 2012;
Snyder et al., 2011).
Beside classical ADs, several other compounds are known to have AD potential. The
neurotrophin BDNF seems to be particularly relevant, since previous data suggests its
involvement in both the development of SRPDs (Castrén, 2005) and the action of ADs
(Saarelainen et al., 2003). Consistently, BDNF rapidly reduces depression-like behavior
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in animal models of depression (Gould et al., 2008; Shirayama et al., 2002). The mood-
stabilizer lithium exerts AD effects in animal models and humans and is widely used to
treat SRPDs (Smith et al., 2011; Holsboer et al., 2012; Worrall et al., 1979). These findings
might explain why BDNF and lithium exert similar adjustments on HTC-waves, when
compared to classical ADs. Furthermore, the observation that the antipsychotic haloperi-
dol and the anxiolytic diazepam, two substances with no AD potential (Airan et al., 2007;
Holsboer et al., 2012) weakened HTC-waves, suggests that the enhancement of HTC-
waves is a characteristic feature of ADs and further support the hypothesis of a common,
circuit-level mechanism of ADs in the HIP.
This "net" outcome of acute pharmacological intervention in the HIP is most likely driven
by diverse molecular and cellular modifications that operate in a drug-specific manner
(Berton and Nestler, 2006; Castrén, 2005; McEwen et al., 2010; Luscher et al., 2011). Sev-
eral studies have examined acute effects of ADs in vitro, but none of these used circuit-
centered approaches, like VSDI and varying results were obtained depending on drug
type and hippocampal subfield under study (Cai et al., 2013; Kobayashi et al., 2008; Ot-
makhova et al., 2005). Population responses in area CA1 of the HIP were found to be un-
changed or even depressed after application of low micromolar concentrations of ADs or
the monoamines serotonin, norepinephrine, and dopamine (Cai et al., 2013; Otmakhova
et al., 2005), while fluoxetine at comparable concentrations facilitated serotonine-induced
amplification of fEPSPs in area CA3 (Kobayashi et al., 2008). Thus, it is not surprising
that a closer inspection of the present data, revealed differences between ADs regard-
ing the position of neuronal activity adjustments in the HTC and their effects as a func-
tion of concentration. At least one concentration of all ADs exerted enhancing effects
on neuronal activity in area CA1. The only exception is tranylcypromine which weak-
ened activity levels at a concentration of 100 nM. Moreover, only fluoxetine, fluvoxamine,
tianeptine, and lithium effects were reminiscent of a classical dose-dependent relation-
ship. All other drugs modified CA1 FDS either at several distinct concentrations (citalo-
pram, venlafaxine) or at a single concentration (TCAs, tranylcypromine, BDNF). In area
CA3, only fluoxetine, venlafaxine, tianeptine, and BDNF enhanced FDSs, although not
all concentrations were effective when compared to CA1 data, whereas tranylcypromine
weakened FDSs at the lowest drug concentration. This analysis further indicates that
enhanced activity in area CA3 is always associated with enhanced activity in area CA1,
which seems obvious, since activity in CA1 neurons is solely driven by action poten-
tial firing of CA3 pyramidal neurons (Figure 3.1A,B). However, enhanced activity in
area CA1 is not necessarily associated with enhanced drive from area CA3, pointing to
isolated (enhancing) effects of ADs on CA1 neurons, although concentrations that dis-
played an increase in CA1 only, always exhibited a trend to higher activity levels in
area CA3. Thus, drug-induced modifications seem to occur in both, area CA3 and area
CA1, which is in agreement with recent research (Cai et al., 2013; Kobayashi et al., 2008;
Kole et al., 2002) and the effects of CSDS. Additionally, DG circuitry seems to be largely
resistant to AD treatment, except for fluvoxamine at 10 µM and venlafaxine at 1 and
10 µM. These findings are in line with previous reports, predominantly demonstrating
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unchanged or depressed neuronal activity in the DG in response to acute AD drug appli-
cation (Birnstiel and Haas, 1991; Watanabe et al., 1993). The relative insensitivity of DG-
FDSs might also be related to the tightly regulated inhibitory network in the DG and the
known habituation of granule cells in response to repeated stimuli (Scharfman et al., 1990;
Teyler and Alger, 1976). Together, these observations and previous research seem to be
quite heterogeneous, what is not surprising, if considering the numerous distinct, region
specific and substance specific effects of acute AD drug administration in the HIP (Bold-
enwatson and Richelson, 1993; Bouron and Chatton, 1999; Cai et al., 2013; Jang et al., 2009;
Kobayashi et al., 2008; Kole et al., 2002; Lenkey et al., 2006; Marchetti et al., 2010; Méndez
et al., 2012; Otmakhova et al., 2005; Rammes and Rupprecht, 2007; Rantamäki et al., 2007;
Rantamäki et al., 2011). Although studies conducted at the molecular or cellular level
(Berton and Nestler, 2006), together with previous research using VSDI in hippocampal
subregions (Airan et al., 2007), yielded essential insights how ADs may modulate neu-
ronal function via diverse physiological adaptions, receptors, and appendant intracellu-
lar signaling cascades, they do not warrant a reliable prediction of a circuit-level mecha-
nism of AD drug action. In turn, the present data is nearly perfectly homogeneous from a
network point of view, which further emphasizes the significance of high-speed imaging
approaches to dissect complex neuronal network dynamics in response to pharmacolog-
ical intervention (Airan et al., 2007; Avrabos et al., 2013; Kim et al., 2012; von Wolff et al.,
2011). Independent from common cellular mechanisms of AD drugs or region specific
changes, at least one concentration increased "net" HTC output. It is important to note
that for direct cortical input the same is true compared to what was discussed in previ-
ous sections. It has been shown that ADs modulate direct cortical inputs (Cai et al., 2013;
Otmakhova et al., 2005), but the prominent effects in the HTC shown here, suggest a
major role of the indirect pathway in mediating acute effects of AD drugs.
As mentioned above, nearly all ADs rapidly and effectively elevate the extracellular con-
centrations of monoamines serotonin or norepinephrine either by blocking their uptake
or by blocking their degradation and the classical model of AD action ("monoamine-
hypothesis") assumes that SRPDs are characterized by a lack of monoamine neurotrans-
mitters and/or an impaired monoamine function in the brain and that AD treatment re-
verse this deficit (Berton and Nestler, 2006; Krishnan and Nestler, 2008; Richelson, 2001).
Thus, the circuit-level effect induced by ADs might be mediated through acute modula-
tion of monoamine neurotransmission or downstream targets of the associated GPCRs
(Richelson, 2001). This seem critical since all ADs tested exert no effect at a concentration
of 100 nM, which is clearly above or close to the Ki for noradrenaline/serotonin reuptake
inhibition of all drugs tested (Boldenwatson and Richelson, 1993; Tatsumi et al., 1997).
Additionally, most of them also exert no effect at a concentration of 500 nM. This might
also explain, why the atypical AD tianeptine (a selective serotonine reuptake enhancer;
McEwen et al., 2010), which is thought to exert its AD effect via modulation of gluta-
matergic signaling (Kole et al., 2002; Pillai et al., 2012), enhanced HTC-waves in a compa-
rable manner. Since hippocampal neurons do not produce monoamines and monoamin-
ergic innervation of the HIP is cut during the slicing procedure (Andersen et al., 2006) low
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ambient monoamine levels are likely present in brain slices that are constantly superfused
with physiological saline (Méndez et al., 2012). This does not exclude contributions from
the monoamine system on a longer timescale involving transcriptional and translational
changes that initiate neuroplastic processes (Krishnan and Nestler, 2008; Castrén, 2005),
but ascribes a major role to monoaminergic-independent mechanisms mediating acute
effects of ADs on HTC-waves. In turn, corroborating evidence suggests that ADs mod-
ulate various other targets at concentrations markedly higher than those required for
norepinephrine/serotonine reuptake inhibition (Cai et al., 2013; Kobayashi et al., 2008;
Méndez et al., 2012; Yang and Kuo, 2002). As one example, ADs interact with GABAergic
interneurons, which mediate perisomatic inhibition onto CA1 pyramidal neurons (Mén-
dez et al., 2012). This seems relevant since interneurons are indispensable for normal in-
formation processing in neuronal networks and their malfunction is related to the patho-
physiology of SRPDs (Luscher et al., 2011). Méndez et al. (2012) showed that ADs reduce
the amplitude of inhibitory synaptic responses in CA1 pyramidal cells by a reduction
of presynaptic GABA release from fast spiking interneurons, a process that might favor
excitation in the hippocampal network. Most importantly, these effects occurred after
chronic treatment of mice but also after acute administration of imipramine and fluoxe-
tine (10 to 20 µM) to brain slices and the effects were still present after pharmacological
occlusion of amine transporters or receptors, whereas lower concentrations of ADs did
not effect GABA release (Méndez et al., 2012).
Acute effects of ADs are of particular interest because they conflict a long standing dogma
in psychiatric research and take up a major drawback of current pharmacological ther-
apies for SRPDs. ADs rapidly modulate several disease-related brain targets, but it
takes weeks to months until they become clinically effective (Krishnan and Nestler, 2008;
Méndez et al., 2012; Saarelainen et al., 2003). However, some authors argue that the
putative delay bases on "ad hoc-propter hoc evidence" from clinical trials that is still un-
critically incorporated into the literature (Katz et al., 2010) and several lines of evidence
suggest that ADs act more rapidly (Katz et al., 2010; Novotný and Faltus, 2003; Stassen et
al., 1997). The most compelling evidence for faster acting compounds comes from the ob-
servation that the anesthetic ketamine produces rapid (minutes to hours) AD responses
in patients suffering from MD and in animal models (of disease) (Berman et al., 2000;
Autry et al., 2011). Accordingly, ketamine amplifies HTC-waves in the same manner as
ADs. In line with this, various acute AD treatment, including all drugs used here, effi-
caciously reduce the time of immobility in the FST, an animal model which is predictive
of AD activity and widely used in psychiatric research for screening of (novel) AD drugs
(Autry et al., 2011; Slattery and Cryan, 2012). But how might acute amplification and
LTP of HTC-waves by ADs be related to clinical efficacy? In agreement with Méndez
et al.’s study, drug effects were only seen with low micromolar concentrations of ADs
in acute experiments, suggesting them to be independent from monoaminergic signal-
ing. Consistently, spectroscopic measurements in animals and humans revealed that such
concentrations are reached after approximately 4 weeks of drug administration, match-
ing the time point at which ADs therapy usually start to be effective (Bolo et al., 2000;
5.3. ANTIDEPRESSANT DRUG ACTION IN THE HIPPOCAMPUS 83
Strauss et al., 1997; Sugita et al., 1989). This suggests that chronic treatment does not
necessarily imply effects to be chronic as well. It still remains elusive, how hippocam-
pal physiology is affected by the various pharmacological intervention in humans and
animals (per os, intravenous, intraperitoneal, intracerebral, intraventricular) and how
distinct brain concentrations develop over time and influence receptor systems and in-
tracellular signaling cascades (Bolo et al., 2000; Strauss et al., 1997). From all this, it is
tempting to speculate that the lengthy treatment with ADs is necessary because ADs fail
to become effective until a certain brain concentration threshold is reached, thus possibly
leading to acute-like effects after appropriate time of AD drug administration (Méndez
et al., 2012).
5.3.2 ANA-12 blocks acute fluoxetine effects
The present work demonstrates that the effects of 10 µM fluoxetine are abolished af-
ter TrkB receptor blockade by ANA-12. Recent evidence suggests a crucial role of neu-
rotrophins and their receptors in mediating the molecular and behavioral actions of ADs
and chronic stress (Duman and Aghajanian, 2012; Krishnan and Nestler, 2008). This
data show that ADs rapidly increase TrkB signaling in the rodent brain in vitro and in
vivo, but the exact mechanism remains elusive (Jang et al., 2009; Koponen et al., 2005;
Rantamäki et al., 2007; Rantamäki et al., 2011; Saarelainen et al., 2003). Some studies
indicate that ADs directly bind to TrkB receptors (Jang et al., 2009), while other reports
suggest that ADs transactivate TrkB receptors via an unknown mechanism and indepen-
dent from BDNF (Rantamäki et al., 2011). Interestingly, Jang et al. (2009) and Rantamäki
et al. (2011) also reported that monoamines are not involved in TrkB activation, which
further supports monoaminergic-independent mechanism of AD drug action. However,
TrkB receptor activation by BDNF or ADs produce acute AD-like responses in rodents
(Saarelainen et al., 2003; Shirayama et al., 2002), while mice with inhibited TrkB signal-
ing or reduced BDNF expression do not respond to ADs in behavioral tests (Saarelainen
et al., 2003). These data suggest that activation of TrkB receptors induced by ADs con-
tributes to their effect in rodents. More indirect evidence also points to reduced BDNF
levels in brains from patients diagnosed with MD and additionally, carriers of a polymor-
phism in the BDNF gene have a decreased hippocampal volume, cognitive impairment,
and are more vulnerable to suffer from SRPDs (Duman and Aghajanian, 2012; Knable et
al., 2004). This might explain, why fluoxetine-mediated amplification of HTC-waves was
abolished under TrkB receptor blockade. Although acute AD treatment does not increase
synthesis of the main ligand of TrkBs, BDNF (Saarelainen et al., 2003), previous research
indicates that acute AD treatment modulates several TrkB-related signaling cascades in-
cluding phosphorylation of CREB, an important upstream regulator of BDNF synthesis
(Rantamäki et al., 2011; Saarelainen et al., 2003). The TrkB-mediated effect of fluoxetine
is of particular interest since all AD tested, including lithium and ketamine, have been
shown to modulate the TrkB receptor - BDNF system (Autry et al., 2011; Jang et al., 2009;
McEwen et al., 2010; Nibuya et al., 1995; Rantamäki et al., 2007; Rantamäki et al., 2011;
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Saarelainen et al., 2003). Whether modulation of neurotrophin signaling might be a com-
mon mechanism underlying the circuit-level effects of drugs with AD potential remains
to determined.
5.3.3 Antidepressants counteract detrimental effects of stress
Stress decreases the strength of HTC-waves and, inversely, ADs increase neuronal activ-
ity percolations through the HTC. This suggest a circuit-level mechanism of AD treat-
ment and chronic stress, that bidirectionally modulate hippocampal activity patterns
(Cai et al., 2013; Malberg and Duman, 2003). This is broadly consistent with a recent
hypothesis in psychiatric research, suggesting that dysregulation of information pro-
cessing in neuronal networks represents a common final pathway of SRPDs. In turn,
ADs are thought to restore the brains capacity to adequately adapt to ongoing environ-
mental changes (Castrén, 2005; Duman and Aghajanian, 2012; Leistedt and Linkowski,
2013). A key assumption of this theory is that new information in the brain is stored
within complex neuronal networks and neurotransmitters are necessary to shape these
networks in a activity-dependent manner (Castrén, 2013). Corroborating evidence comes
from studies showing similar bidirectional effects of chronic stress and ADs in neuronal
networks (Castrén, 2005; Malberg and Duman, 2003; Santarelli et al., 2003; Snyder et al.,
2011). Within this framework, the modulation of HTC-waves may represent a critical first
step that rapidly improves activity patterns in the hippocampal network. One candidate
mechanism through which chronic stress and AD might influence network function on
longer timescales is TrkB activation and subsequent alteration of BDNF signaling, which
have been implicated in both, the adverse changes in response to chronic stress and AD
treatment (Duman and Aghajanian, 2012; Saarelainen et al., 2003). The network hypoth-
esis of SRPDs also constitutes a framework for the high comorbidity among SRPDs and
their highly overlapping symptom criteria, which is in line with the fact that ADs are ef-
fectively used to treat a variety of brain-related diseases (Duman and Aghajanian, 2012;
Porsteinsson et al., 2014; Ressler and Mayberg, 2007). However, the observation that
many patients relapse to disease even after years of AD treatment argues that pharma-
cological intervention necessarily triggers other, slower processes such as neurotrophic
factor expression and structural plasticity (Duman and Aghajanian, 2012; Krishnan and
Nestler, 2008).
In conclusion, this data strongly suggests that AD drug-induced enhancement of HTC-
waves is independent from a common cellular mechanism, including monoaminergic
signaling. Instead, it is conceivable that these widely used therapeutics mediate their
acute effects via a circuit-level effect in the HIP, a novel pharmacological trajectory for
their AD properties. These findings underscore the necessity to consider more circuit-
centered approaches in psychiatric research to find novel therapeutic approaches for the
treatment of SRPDs.
Chapter 6
Future perspective
With the development and characterization of the HTC-wave assay, this dissertation has
given an account of and the reasons for the use of circuit-centered approaches as powerful
tools to uncover physiologically meaningful neuronal network patterns in the HIP. The
empirical findings in this study provide a new understanding how hippocampal neurons
selectively respond to entorhinal activity in a frequency and duration-dependent manner.
Obviously, they can distinguish relevant and, thus, potentially recollection-worth input
from irrelevant one, permitting only significant information presented for a sufficient pe-
riod to be gated through the HTC for subsequent long-term storage.
There are plenty possible approaches where to go next and how to increase the predictive
significance of HTC-waves. It would be of great interest to optogenetically manipulate
small sets of entorhinal or DG neurons, or to directly test the existence of HTC-waves on
the level of sparse numbers. The light-induced activation of excitatory or inhibitory neu-
rons throughout the HF just as the manipulation of selective neurotransmitter system in a
polysynaptic setting may also greatly facilitate the understanding of hippocampal signal
processing. Direct innervation of areas CA3 and CA1 was functionally inactivated in the
present study. Including these pathways by selective and temporally precise activation or
inhibition, either electrically or optogenetically, may also provide further knowledge of
their contribution in a comprehensive, hence circuit-centered manner (Suh et al., 2011).
ADs and chronic stress likely affect the HIP via a multitude of molecular, cellular and
structural modifications (Duric and Duman, 2013). The present data provides a circuit-
level mechanism how these alterations are integrated in a neuronal network, providing
interesting applications for future research. The HTC-wave assay might be a valuable
tool for screening novel AD drugs, regarding their efficacy to modulate activity flow in
the HIP or to directly counteract stress-induced hippocampal impairment in animal mod-
els. Although the study has successfully demonstrated that ADs enhance HTC-waves at
low micromolar concentrations, it has certain limitations in terms of restricted availabil-
ity of research investigating therapeutically relevant brain concentrations of these drugs
(Bolo et al., 2000; Strauss et al., 1997). Further work needs to be done to establish how
brain concentrations of ADs develop over time an how they are associated with clinical
efficacy and modulation of specific brain targets.
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Beside pharmacological intervention, HTC-waves provide a potent assay to observe neu-
ronal network dynamics in genetically modified animals. For instance, manipulation of
neurogenesis in the HIP seems worthwhile, since this mechanism has repeatedly recog-
nized to be involved in AD drug action (Eisch and Petrik, 2012; Santarelli et al., 2003).
Furthermore, comparable network approaches are applicable to other brain regions, in-
cluding the amygdala and the prefrontal cortex, which may help to elucidate the impact
of ADs and chronic stress on a broader neurocircuitry that is likely involved in the patho-
physiology of SRPDs (Avrabos et al., 2013; Radley, 2012).
Chapter 7
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Tab. 8.1. Chemicals
SUBSTANCE CHEMICAL NAME SUPPLIER SOLVING
MEDIUM
ANA-12 N-[2-[[(hexahydro-2-oxo-1H-azepin-3-
yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide
Tocris Aqua dest.
BDNF Brain derived neurotrophic factor, human recombinant
(rHuBDNF)
Biomol Aqua dest.
AMITRIPTYLINE HYDROCHLORIDE 3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-
dimethyl-1-propanamine hydrochloride
Sigma-Aldrich ACSF
1(S),9(R)-(-)-BICUCULLINE METHIODIDE [R-(R*,S*)]-5-(6,8-Dihydro-8-oxofuro[3,4-e]-1,3-benzodioxol-
6-yl)-5,6,7,8-tetrahydro-6,6-dimethyl-1,3-dioxolo[4,5-
g]isoquinolinium iodide
Sigma-Aldrich ACSF
CAFFEINE 1,3,7-Trimethylxanthine Sigma-Aldrich ACSF
CITALOPRAM HYDROBROMIDE 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-
isobenzofurancarbonitrile hydrobromide
Sigma-Aldrich ACSF
CORTICOSTERONE 11β,21-Dihydroxy-4-pregnene-3,20-dione,11β,21-
Dihydroxyprogesterone
Sigma-Aldrich Ethanol
CLOMIPRAMINE HYDROCHLORIDE 3-Chloro-10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-
propanamine hydrochloride
Sigma-Aldrich ACSF
CRH Corticotropine-releasing hormone Abcam ACSF
D-APV D-(-)-2-Amino-5-phosphonopentanoic acid Abcam ACSF
DMSO Dimethyl sulfoxide Sigma-Aldrich -
DCG-IV (2S,2’R,3’R)-2-(2’,3’-dicarboxycyclopropyl)glycine Tocris bioscience ACSF
DI-4-ANEPPS 4-(2-(6-(Dibutylamino)-2-naphthalenyl)ethenyl)-1-(3-
sulfopropyl)pyridinium hydroxide inner salt
Sigma-Aldrich DMSO
DIAZEPAM 7-Chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2(1H)-one Sigma-Aldrich DMSO
FLUVOXAMINE MALEATE (E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone-O-(2-
aminoethyl)oxime maleate
Sigma-Aldrich ACSF
FLUO Fluoresceine Sigma-Aldrich ACSF
FLUOXETINE HYDROCHLORIDE (±)-N-Methyl-y-[4-(trifluoromethyl)phenoxy]benzenepropanamine
hydrochloride
Sigma-Aldrich Aqua dest.
HALOPERIDOL 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-
fluorophenyl)-1-butanone
Sigma-Aldrich DMSO
ISOFLURANE (±)-Difluormethoxy-1-chlor-2,2,2-trifluorethan Abbott -
KETAMINE S-(+)-ketamine hydrochloride Sigma-Aldrich Aqua dest.
LITHIUM CHLORIDE - Sigma-Aldrich Aqua dest.
NBQX DISODIUM SALT 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[ι]quinoxaline-7-
sulfonamide disodium salt
Abcam ACSF
PONCEAU S 3-Hydroxy-4-(2-sulfo-4-[4-sulfophenylazo]phenylazo)-2,7-
naphthalenedisulfonic acid sodium salt
Sigma-Aldrich Aqua dest.
TRANYLCYPROMINE HYDROCHLORIDE Trans-2-phenylcyclopropylamine hydrochloride Sigma-Aldrich ACSF
ACSF SALTS - Sigma Aldrich Aqua dest.
TIANEPTINE SODIUM SALT 7-[(3-Chloro-6,11-dihydro-6-methyl–5,5-
dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid
sodium salt
Tocris bioscience Aqua dest.
VENLAFAXINE HYDROCHLORIDE (+/-)-1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol
hydrochloride
Sigma-Aldrich ACSF
(Abcam, Cambridge, UK; Abbott, Chicago, USA; Biomol, Hamburg, Germany; Sigma-Aldrich, St. Louis, USA; Tocris, Bristol, UK)
